MXPA06007173A - Derivados de aminoalcohol. - Google Patents
Derivados de aminoalcohol.Info
- Publication number
- MXPA06007173A MXPA06007173A MXPA06007173A MXPA06007173A MXPA06007173A MX PA06007173 A MXPA06007173 A MX PA06007173A MX PA06007173 A MXPA06007173 A MX PA06007173A MX PA06007173 A MXPA06007173 A MX PA06007173A MX PA06007173 A MXPA06007173 A MX PA06007173A
- Authority
- MX
- Mexico
- Prior art keywords
- amino
- ethyl
- hydroxy
- phenylethyl
- broad
- Prior art date
Links
- 150000001414 amino alcohols Chemical class 0.000 title description 16
- 150000001875 compounds Chemical class 0.000 claims abstract description 171
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 140
- 150000003839 salts Chemical class 0.000 claims abstract description 70
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 68
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 44
- 239000001257 hydrogen Substances 0.000 claims abstract description 43
- 150000002431 hydrogen Chemical group 0.000 claims abstract description 23
- 125000006239 protecting group Chemical group 0.000 claims abstract description 13
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims abstract description 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 10
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 9
- 150000002367 halogens Chemical group 0.000 claims abstract description 9
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims abstract description 8
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 7
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims abstract description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 6
- 230000001225 therapeutic effect Effects 0.000 claims abstract description 4
- 230000000069 prophylactic effect Effects 0.000 claims abstract description 3
- -1 benzyloxy, nitro, amino Chemical group 0.000 claims description 259
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 142
- 238000002360 preparation method Methods 0.000 claims description 105
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims description 46
- 125000002933 cyclohexyloxy group Chemical group C1(CCCCC1)O* 0.000 claims description 23
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 239000002253 acid Substances 0.000 claims description 13
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 12
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 11
- 125000000623 heterocyclic group Chemical group 0.000 claims description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 7
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 7
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 5
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 5
- 206010020853 Hypertonic bladder Diseases 0.000 claims description 4
- 125000003282 alkyl amino group Chemical group 0.000 claims description 4
- 102000016959 beta-3 Adrenergic Receptors Human genes 0.000 claims description 4
- 108010014502 beta-3 Adrenergic Receptors Proteins 0.000 claims description 4
- 125000001589 carboacyl group Chemical group 0.000 claims description 4
- 208000035475 disorder Diseases 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 238000003379 elimination reaction Methods 0.000 claims description 4
- YLQMAAMFQNYJDU-MHZLTWQESA-N 2-cyclohexyloxy-4-[4-[2-[[(2r)-2-hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]-n-methylsulfonylbenzamide Chemical compound CS(=O)(=O)NC(=O)C1=CC=C(C=2C=CC(CCNC[C@H](O)C=3C=NC=CC=3)=CC=2)C=C1OC1CCCCC1 YLQMAAMFQNYJDU-MHZLTWQESA-N 0.000 claims description 3
- 208000018522 Gastrointestinal disease Diseases 0.000 claims description 3
- 208000008589 Obesity Diseases 0.000 claims description 3
- 208000009722 Overactive Urinary Bladder Diseases 0.000 claims description 3
- 206010033645 Pancreatitis Diseases 0.000 claims description 3
- 208000025865 Ulcer Diseases 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 3
- 239000000556 agonist Substances 0.000 claims description 3
- 238000007257 deesterification reaction Methods 0.000 claims description 3
- 206010012601 diabetes mellitus Diseases 0.000 claims description 3
- 125000006125 ethylsulfonyl group Chemical group 0.000 claims description 3
- 125000001475 halogen functional group Chemical group 0.000 claims description 3
- 235000020824 obesity Nutrition 0.000 claims description 3
- 208000020629 overactive bladder Diseases 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 125000004076 pyridyl group Chemical group 0.000 claims description 3
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 3
- 231100000397 ulcer Toxicity 0.000 claims description 3
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims description 2
- HXFKZSVPCHUKBX-VWLOTQADSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-n-methylsulfonyl-2-propan-2-ylsulfanylbenzamide Chemical compound C1=C(C(=O)NS(C)(=O)=O)C(SC(C)C)=CC(C=2C=CC(CCNC[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 HXFKZSVPCHUKBX-VWLOTQADSA-N 0.000 claims description 2
- 125000005236 alkanoylamino group Chemical group 0.000 claims description 2
- 125000004414 alkyl thio group Chemical group 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- HGOKKKSGWRCIHE-NDEPHWFRSA-N n-[2-cyclohexyloxy-4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]phenyl]sulfonylacetamide Chemical compound CC(=O)NS(=O)(=O)C1=CC=C(C=2C=CC(CCNC[C@H](O)C=3C=CC=CC=3)=CC=2)C=C1OC1CCCCC1 HGOKKKSGWRCIHE-NDEPHWFRSA-N 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 125000005554 pyridyloxy group Chemical group 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 claims 4
- KQTRLFCXXWVHEX-DCFHFQCYSA-N 2-(2-ethoxyethylsulfanyl)-4-[4-[2-[[(1r,2s)-1-hydroxy-1-phenylpropan-2-yl]amino]ethyl]phenyl]benzoic acid Chemical compound C1=C(C(O)=O)C(SCCOCC)=CC(C=2C=CC(CCN[C@@H](C)[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 KQTRLFCXXWVHEX-DCFHFQCYSA-N 0.000 claims 1
- YMRNZNHFJGQDCB-UHFFFAOYSA-N 2-amino-3-phenylbenzoic acid Chemical compound NC1=C(C(O)=O)C=CC=C1C1=CC=CC=C1 YMRNZNHFJGQDCB-UHFFFAOYSA-N 0.000 claims 1
- WWFRXUDMACTFBI-NDEPHWFRSA-N 2-cyclohexyloxy-4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-n-methylsulfonylbenzamide Chemical compound CS(=O)(=O)NC(=O)C1=CC=C(C=2C=CC(CCNC[C@H](O)C=3C=CC=CC=3)=CC=2)C=C1OC1CCCCC1 WWFRXUDMACTFBI-NDEPHWFRSA-N 0.000 claims 1
- VEVOQLCIKVDLFH-MMTVBGGISA-N 2-cyclopentyl-4-[4-[2-[[(1r,2s)-1-hydroxy-1-phenylpropan-2-yl]amino]ethyl]phenyl]benzoic acid Chemical compound N([C@@H](C)[C@H](O)C=1C=CC=CC=1)CCC(C=C1)=CC=C1C(C=1)=CC=C(C(O)=O)C=1C1CCCC1 VEVOQLCIKVDLFH-MMTVBGGISA-N 0.000 claims 1
- SITWWMFSARAANL-KMRXNPHXSA-N 4-[4-[2-[[(1r,2s)-1-hydroxy-1-phenylpropan-2-yl]amino]ethyl]phenyl]-2-(2-methylpropyl)-n-methylsulfonylbenzamide Chemical compound C1=C(C(=O)NS(C)(=O)=O)C(CC(C)C)=CC(C=2C=CC(CCN[C@@H](C)[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 SITWWMFSARAANL-KMRXNPHXSA-N 0.000 claims 1
- NIITYICIHYXXSW-DCFHFQCYSA-N 4-[4-[2-[[(1r,2s)-1-hydroxy-1-phenylpropan-2-yl]amino]ethyl]phenyl]-2-(2-methylpropyl)benzoic acid Chemical compound C1=C(C(O)=O)C(CC(C)C)=CC(C=2C=CC(CCN[C@@H](C)[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 NIITYICIHYXXSW-DCFHFQCYSA-N 0.000 claims 1
- WVYCDLWTGGHFDH-SIBVEZHUSA-N 4-[4-[2-[[(1r,2s)-1-hydroxy-1-phenylpropan-2-yl]amino]ethyl]phenyl]-2-propan-2-yloxybenzoic acid Chemical compound C1=C(C(O)=O)C(OC(C)C)=CC(C=2C=CC(CCN[C@@H](C)[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 WVYCDLWTGGHFDH-SIBVEZHUSA-N 0.000 claims 1
- PCAWFRXYKXISJG-SIBVEZHUSA-N 4-[4-[2-[[(1r,2s)-1-hydroxy-1-phenylpropan-2-yl]amino]ethyl]phenyl]-2-propan-2-ylsulfanylbenzoic acid Chemical compound C1=C(C(O)=O)C(SC(C)C)=CC(C=2C=CC(CCN[C@@H](C)[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 PCAWFRXYKXISJG-SIBVEZHUSA-N 0.000 claims 1
- BAYKLYYVFBMQAJ-SIBVEZHUSA-N 4-[4-[2-[[(1r,2s)-1-hydroxy-1-phenylpropan-2-yl]amino]ethyl]phenyl]-2-propoxybenzoic acid Chemical compound C1=C(C(O)=O)C(OCCC)=CC(C=2C=CC(CCN[C@@H](C)[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 BAYKLYYVFBMQAJ-SIBVEZHUSA-N 0.000 claims 1
- BWYBAWPQJCABAZ-QFIPXVFZSA-N 4-[4-[2-[[(2r)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]ethylamino]phenyl]benzoic acid Chemical compound C([C@H](O)C=1C=C(Cl)C=CC=1)NCCNC(C=C1)=CC=C1C1=CC=C(C(O)=O)C=C1 BWYBAWPQJCABAZ-QFIPXVFZSA-N 0.000 claims 1
- FKGYWDPSUXSSQK-MHZLTWQESA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-2-(2-methylpropyl)-n-methylsulfonylbenzamide Chemical compound C1=C(C(=O)NS(C)(=O)=O)C(CC(C)C)=CC(C=2C=CC(CCNC[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 FKGYWDPSUXSSQK-MHZLTWQESA-N 0.000 claims 1
- FYONCJXSNAVJFY-DEOSSOPVSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-2-propan-2-ylsulfanylbenzoic acid Chemical compound C1=C(C(O)=O)C(SC(C)C)=CC(C=2C=CC(CCNC[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 FYONCJXSNAVJFY-DEOSSOPVSA-N 0.000 claims 1
- FVWXDJPYOPAWEZ-SANMLTNESA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-3-(2-methylpropyl)benzoic acid Chemical compound CC(C)CC1=CC(C(O)=O)=CC=C1C(C=C1)=CC=C1CCNC[C@H](O)C1=CC=CC=C1 FVWXDJPYOPAWEZ-SANMLTNESA-N 0.000 claims 1
- YKDNCRQUBMFUKT-QHCPKHFHSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]-2-propan-2-ylsulfanylbenzoic acid Chemical compound C1=C(C(O)=O)C(SC(C)C)=CC(C=2C=CC(CCNC[C@H](O)C=3C=NC=CC=3)=CC=2)=C1 YKDNCRQUBMFUKT-QHCPKHFHSA-N 0.000 claims 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 101150032584 oxy-4 gene Proteins 0.000 claims 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 503
- 239000000203 mixture Substances 0.000 description 278
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 277
- 239000000243 solution Substances 0.000 description 182
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 171
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 160
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 153
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 147
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 137
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 107
- 239000012267 brine Substances 0.000 description 96
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 96
- 230000002829 reductive effect Effects 0.000 description 94
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 93
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 80
- 239000012044 organic layer Substances 0.000 description 80
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 75
- 235000019341 magnesium sulphate Nutrition 0.000 description 75
- 239000011734 sodium Substances 0.000 description 73
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 61
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 57
- 239000007787 solid Substances 0.000 description 55
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 52
- 239000000741 silica gel Substances 0.000 description 50
- 229910002027 silica gel Inorganic materials 0.000 description 50
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 46
- 238000001914 filtration Methods 0.000 description 45
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 44
- 238000004440 column chromatography Methods 0.000 description 43
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 40
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 40
- 239000000047 product Substances 0.000 description 38
- 238000001704 evaporation Methods 0.000 description 37
- 230000008020 evaporation Effects 0.000 description 37
- 239000007864 aqueous solution Substances 0.000 description 34
- 239000011541 reaction mixture Substances 0.000 description 34
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 33
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 26
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 26
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 25
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 24
- 229910052757 nitrogen Inorganic materials 0.000 description 22
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 21
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 20
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 19
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 19
- 229910052938 sodium sulfate Inorganic materials 0.000 description 19
- 235000011152 sodium sulphate Nutrition 0.000 description 19
- 239000000725 suspension Substances 0.000 description 19
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 18
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 18
- 238000001816 cooling Methods 0.000 description 17
- 239000003480 eluent Substances 0.000 description 17
- XBXCNNQPRYLIDE-UHFFFAOYSA-M n-tert-butylcarbamate Chemical compound CC(C)(C)NC([O-])=O XBXCNNQPRYLIDE-UHFFFAOYSA-M 0.000 description 17
- 238000010992 reflux Methods 0.000 description 17
- 238000010898 silica gel chromatography Methods 0.000 description 17
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 15
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 15
- 238000000034 method Methods 0.000 description 15
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 14
- 239000010410 layer Substances 0.000 description 14
- 239000002244 precipitate Substances 0.000 description 14
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 13
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 13
- 239000000706 filtrate Substances 0.000 description 13
- 229910000029 sodium carbonate Inorganic materials 0.000 description 13
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 12
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 12
- 230000002265 prevention Effects 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 11
- 239000012043 crude product Substances 0.000 description 11
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 11
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 10
- 101150041968 CDC13 gene Proteins 0.000 description 10
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 10
- 239000006260 foam Substances 0.000 description 10
- 125000004433 nitrogen atom Chemical group N* 0.000 description 10
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 10
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 9
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 8
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 125000002911 monocyclic heterocycle group Chemical group 0.000 description 8
- 239000012299 nitrogen atmosphere Substances 0.000 description 8
- 229910000027 potassium carbonate Inorganic materials 0.000 description 8
- 235000011181 potassium carbonates Nutrition 0.000 description 8
- 229920006395 saturated elastomer Chemical group 0.000 description 8
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 8
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 8
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 7
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 7
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 7
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 7
- MVEAAGBEUOMFRX-UHFFFAOYSA-N ethyl acetate;hydrochloride Chemical compound Cl.CCOC(C)=O MVEAAGBEUOMFRX-UHFFFAOYSA-N 0.000 description 7
- 230000036724 intravesical pressure Effects 0.000 description 7
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 7
- 239000005711 Benzoic acid Substances 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 235000010233 benzoic acid Nutrition 0.000 description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 6
- 238000004587 chromatography analysis Methods 0.000 description 6
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 6
- 125000004430 oxygen atom Chemical group O* 0.000 description 6
- 235000011056 potassium acetate Nutrition 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- ZQQSRVPOAHYHEL-UHFFFAOYSA-N 4-bromo-2-fluorobenzoic acid Chemical compound OC(=O)C1=CC=C(Br)C=C1F ZQQSRVPOAHYHEL-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 5
- ODWXUNBKCRECNW-UHFFFAOYSA-M bromocopper(1+) Chemical compound Br[Cu+] ODWXUNBKCRECNW-UHFFFAOYSA-M 0.000 description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- DRURZIUKZXJUGF-JEFWXSHNSA-N 4-[4-[2-[(2-methylpropan-2-yl)oxycarbonyl-[(2r)-2-(oxan-2-yloxy)-2-phenylethyl]amino]ethyl]phenyl]-2-propan-2-yloxybenzoic acid Chemical compound C1=C(C(O)=O)C(OC(C)C)=CC(C=2C=CC(CCN(C[C@H](OC3OCCCC3)C=3C=CC=CC=3)C(=O)OC(C)(C)C)=CC=2)=C1 DRURZIUKZXJUGF-JEFWXSHNSA-N 0.000 description 4
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 4
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- PCBZRNYXXCIELG-WYFCWLEVSA-N COC1=CC=C(C[C@H](NC(=O)OC2CCCC3(C2)OOC2(O3)C3CC4CC(C3)CC2C4)C(=O)N[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O)N2C=NC3=C2N=CN=C3N(C)C)C=C1 Chemical compound COC1=CC=C(C[C@H](NC(=O)OC2CCCC3(C2)OOC2(O3)C3CC4CC(C3)CC2C4)C(=O)N[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O)N2C=NC3=C2N=CN=C3N(C)C)C=C1 PCBZRNYXXCIELG-WYFCWLEVSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- AIXAANGOTKPUOY-UHFFFAOYSA-N carbachol Chemical compound [Cl-].C[N+](C)(C)CCOC(N)=O AIXAANGOTKPUOY-UHFFFAOYSA-N 0.000 description 4
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 4
- FCZCIXQGZOUIDN-UHFFFAOYSA-N ethyl 2-diethoxyphosphinothioyloxyacetate Chemical compound CCOC(=O)COP(=S)(OCC)OCC FCZCIXQGZOUIDN-UHFFFAOYSA-N 0.000 description 4
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 4
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 4
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 4
- 125000004434 sulfur atom Chemical group 0.000 description 4
- HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- IWYDHOAUDWTVEP-SSDOTTSWSA-N (R)-mandelic acid Chemical compound OC(=O)[C@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-SSDOTTSWSA-N 0.000 description 3
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 3
- SQFJIWMBUCPKCR-UHFFFAOYSA-N 2-(4-iodophenoxy)ethanamine;hydrochloride Chemical compound Cl.NCCOC1=CC=C(I)C=C1 SQFJIWMBUCPKCR-UHFFFAOYSA-N 0.000 description 3
- LRSJEFXLCJPRJC-HNNXBMFYSA-N 3-(4-bromophenyl)-n-[(2r)-2-hydroxy-2-pyridin-3-ylethyl]propanamide Chemical compound C([C@H](O)C=1C=NC=CC=1)NC(=O)CCC1=CC=C(Br)C=C1 LRSJEFXLCJPRJC-HNNXBMFYSA-N 0.000 description 3
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 239000005695 Ammonium acetate Substances 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- OCSOHUROTFFTFO-QMMMGPOBSA-N [(2r)-2-hydroxy-2-phenylethyl] carbamate Chemical compound NC(=O)OC[C@H](O)C1=CC=CC=C1 OCSOHUROTFFTFO-QMMMGPOBSA-N 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 235000019257 ammonium acetate Nutrition 0.000 description 3
- 229940043376 ammonium acetate Drugs 0.000 description 3
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 3
- 239000000908 ammonium hydroxide Substances 0.000 description 3
- 239000004305 biphenyl Substances 0.000 description 3
- 235000010290 biphenyl Nutrition 0.000 description 3
- 229960004484 carbachol Drugs 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 3
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 3
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 2
- STGOQIDJESATGC-CKUXDGONSA-N (1r)-2-[2-(4-bromophenyl)ethylamino]-1-pyridin-3-ylethanol;dihydrochloride Chemical compound Cl.Cl.C([C@H](O)C=1C=NC=CC=1)NCCC1=CC=C(Br)C=C1 STGOQIDJESATGC-CKUXDGONSA-N 0.000 description 2
- XOXFCHXCHRZRDY-INIZCTEOSA-N (1r)-2-[2-(4-iodophenoxy)ethylamino]-1-(4-nitrophenyl)ethanol Chemical compound C([C@H](O)C=1C=CC(=CC=1)[N+]([O-])=O)NCCOC1=CC=C(I)C=C1 XOXFCHXCHRZRDY-INIZCTEOSA-N 0.000 description 2
- IWHXMQRURZTACM-INIZCTEOSA-N (1r)-2-[3-(4-bromophenyl)propylamino]-1-pyridin-3-ylethanol Chemical compound C([C@H](O)C=1C=NC=CC=1)NCCCC1=CC=C(Br)C=C1 IWHXMQRURZTACM-INIZCTEOSA-N 0.000 description 2
- PENZKJBQPMYHLW-UHFFFAOYSA-N (4-bromo-2-cyclohexyloxyphenyl)methanol Chemical compound OCC1=CC=C(Br)C=C1OC1CCCCC1 PENZKJBQPMYHLW-UHFFFAOYSA-N 0.000 description 2
- AWMVMTVKBNGEAK-QMMMGPOBSA-N (R)-styrene oxide Chemical compound C1O[C@@H]1C1=CC=CC=C1 AWMVMTVKBNGEAK-QMMMGPOBSA-N 0.000 description 2
- YKIUTLHCSNCTDZ-QMMMGPOBSA-N (r)-4-nitrostyrene oxide Chemical compound C1=CC([N+](=O)[O-])=CC=C1[C@H]1OC1 YKIUTLHCSNCTDZ-QMMMGPOBSA-N 0.000 description 2
- NHOJLWXCTCQCPB-UHFFFAOYSA-N 2-(4-bromo-2-cyclohexyloxyphenyl)acetic acid Chemical compound OC(=O)CC1=CC=C(Br)C=C1OC1CCCCC1 NHOJLWXCTCQCPB-UHFFFAOYSA-N 0.000 description 2
- UYJPAIJUGRVSHR-UHFFFAOYSA-N 2-(4-bromo-2-cyclohexyloxyphenyl)acetonitrile Chemical compound BrC1=CC=C(CC#N)C(OC2CCCCC2)=C1 UYJPAIJUGRVSHR-UHFFFAOYSA-N 0.000 description 2
- MMUFFQLBFULXDJ-AWEZNQCLSA-N 2-(4-bromophenyl)-n-[(2r)-2-hydroxy-2-pyridin-3-ylethyl]acetamide Chemical compound C([C@H](O)C=1C=NC=CC=1)NC(=O)CC1=CC=C(Br)C=C1 MMUFFQLBFULXDJ-AWEZNQCLSA-N 0.000 description 2
- CMRQIELSCFJHBQ-UHFFFAOYSA-N 2-(4-iodophenoxy)ethanamine Chemical compound NCCOC1=CC=C(I)C=C1 CMRQIELSCFJHBQ-UHFFFAOYSA-N 0.000 description 2
- CFSOYOQSDOBDBK-TYIYNAFKSA-N 2-cyclohexyloxy-4-[4-[2-[(2-methylpropan-2-yl)oxycarbonyl-[(2r)-2-(oxan-2-yloxy)-2-phenylethyl]amino]ethyl]phenyl]benzoic acid Chemical compound C([C@H](OC1OCCCC1)C=1C=CC=CC=1)N(C(=O)OC(C)(C)C)CCC(C=C1)=CC=C1C(C=1)=CC=C(C(O)=O)C=1OC1CCCCC1 CFSOYOQSDOBDBK-TYIYNAFKSA-N 0.000 description 2
- NOWXHHGGSFXBBC-HKBQPEDESA-N 2-cyclohexyloxy-4-[4-[3-[[(2r)-2-hydroxy-2-phenylethyl]-[(2-methylpropan-2-yl)oxycarbonyl]amino]propyl]phenyl]benzoic acid Chemical compound C([C@H](O)C=1C=CC=CC=1)N(C(=O)OC(C)(C)C)CCCC(C=C1)=CC=C1C(C=1)=CC=C(C(O)=O)C=1OC1CCCCC1 NOWXHHGGSFXBBC-HKBQPEDESA-N 0.000 description 2
- ILYSAKHOYBPSPC-UHFFFAOYSA-N 2-phenylbenzoic acid Chemical compound OC(=O)C1=CC=CC=C1C1=CC=CC=C1 ILYSAKHOYBPSPC-UHFFFAOYSA-N 0.000 description 2
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 2
- WSHIIAOBOIOENJ-UHFFFAOYSA-N 3-(4-bromophenyl)propan-1-amine Chemical compound NCCCC1=CC=C(Br)C=C1 WSHIIAOBOIOENJ-UHFFFAOYSA-N 0.000 description 2
- MSYVIHNLCVUBFM-UHFFFAOYSA-N 3-(4-bromophenyl)propanamide Chemical compound NC(=O)CCC1=CC=C(Br)C=C1 MSYVIHNLCVUBFM-UHFFFAOYSA-N 0.000 description 2
- NCSTWHYWOVZDOC-UHFFFAOYSA-N 3-(4-bromophenyl)propanoic acid Chemical compound OC(=O)CCC1=CC=C(Br)C=C1 NCSTWHYWOVZDOC-UHFFFAOYSA-N 0.000 description 2
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- QOWSWEBLNVACCL-UHFFFAOYSA-N 4-Bromophenyl acetate Chemical compound OC(=O)CC1=CC=C(Br)C=C1 QOWSWEBLNVACCL-UHFFFAOYSA-N 0.000 description 2
- JAYBQRKXEFDRER-RCOVLWMOSA-N 4-Hydroxynorephedrine Chemical compound C[C@H](N)[C@H](O)C1=CC=C(O)C=C1 JAYBQRKXEFDRER-RCOVLWMOSA-N 0.000 description 2
- IVPRQKNOHWKUCW-UHFFFAOYSA-N 4-[4-(2-bromoethoxy)phenyl]-n-methylsulfonyl-2-propan-2-ylsulfanylbenzamide Chemical compound C1=C(C(=O)NS(C)(=O)=O)C(SC(C)C)=CC(C=2C=CC(OCCBr)=CC=2)=C1 IVPRQKNOHWKUCW-UHFFFAOYSA-N 0.000 description 2
- GBHVJUPUEBQFCC-UHFFFAOYSA-N 4-[4-(2-bromoethyl)phenyl]-n-methylsulfonyl-2-propan-2-yloxybenzamide Chemical compound C1=C(C(=O)NS(C)(=O)=O)C(OC(C)C)=CC(C=2C=CC(CCBr)=CC=2)=C1 GBHVJUPUEBQFCC-UHFFFAOYSA-N 0.000 description 2
- RPCYTURSSUBLFL-OBRDHALPSA-N 4-[4-[2-[[(1r,2s)-1-hydroxy-1-phenylpropan-2-yl]amino]ethyl]phenyl]-2-(2-methylpropyl)benzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(CC(C)C)=CC(C=2C=CC(CCN[C@@H](C)[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 RPCYTURSSUBLFL-OBRDHALPSA-N 0.000 description 2
- RMOVBAROZIXQLV-MHZLTWQESA-N 4-[4-[2-[[(2r)-2-hydroxy-2-pyridin-3-ylethyl]-[(2-methylpropan-2-yl)oxycarbonyl]amino]ethyl]phenyl]-2-(2-methylpropoxy)benzoic acid Chemical compound C1=C(C(O)=O)C(OCC(C)C)=CC(C=2C=CC(CCN(C[C@H](O)C=3C=NC=CC=3)C(=O)OC(C)(C)C)=CC=2)=C1 RMOVBAROZIXQLV-MHZLTWQESA-N 0.000 description 2
- WLZBUJPAVQWCNF-VWLOTQADSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]-n-methylsulfonyl-2-(propan-2-ylamino)benzamide Chemical compound C1=C(C(=O)NS(C)(=O)=O)C(NC(C)C)=CC(C=2C=CC(CCNC[C@H](O)C=3C=NC=CC=3)=CC=2)=C1 WLZBUJPAVQWCNF-VWLOTQADSA-N 0.000 description 2
- LTNKWDTWXPWBNJ-UHFFFAOYSA-N 4-bromo-2-(2-methylpropoxy)benzoic acid Chemical compound CC(C)COC1=CC(Br)=CC=C1C(O)=O LTNKWDTWXPWBNJ-UHFFFAOYSA-N 0.000 description 2
- IGUFRPIGTQBSEU-UHFFFAOYSA-N 4-bromo-2-(3-methylbutyl)-n-methylsulfonylbenzamide Chemical compound CC(C)CCC1=CC(Br)=CC=C1C(=O)NS(C)(=O)=O IGUFRPIGTQBSEU-UHFFFAOYSA-N 0.000 description 2
- PVDJBEGCLOOENV-UHFFFAOYSA-N 4-bromo-2-cyclohexyloxybenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=C(Br)C=C1OC1CCCCC1 PVDJBEGCLOOENV-UHFFFAOYSA-N 0.000 description 2
- ZCPVDHZKGQQHDS-UHFFFAOYSA-N 4-bromo-2-fluorobenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=C(Br)C=C1F ZCPVDHZKGQQHDS-UHFFFAOYSA-N 0.000 description 2
- IRQPDGFKSOMQML-UHFFFAOYSA-N 4-bromo-2-propan-2-ylsulfanylbenzoic acid Chemical compound CC(C)SC1=CC(Br)=CC=C1C(O)=O IRQPDGFKSOMQML-UHFFFAOYSA-N 0.000 description 2
- YCVKSVXTOILHJB-UHFFFAOYSA-N 4-bromo-n-methylsulfonyl-2-propan-2-ylsulfanylbenzamide Chemical compound CC(C)SC1=CC(Br)=CC=C1C(=O)NS(C)(=O)=O YCVKSVXTOILHJB-UHFFFAOYSA-N 0.000 description 2
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 2
- VSMDINRNYYEDRN-UHFFFAOYSA-N 4-iodophenol Chemical compound OC1=CC=C(I)C=C1 VSMDINRNYYEDRN-UHFFFAOYSA-N 0.000 description 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- SSUFDOMYCBCHML-UHFFFAOYSA-N CCCCC[S](=O)=O Chemical group CCCCC[S](=O)=O SSUFDOMYCBCHML-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 2
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 2
- HRUMHQQXUYKRJK-UHFFFAOYSA-N [4-[2-[benzyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]ethyl]phenyl]boronic acid Chemical compound C=1C=CC=CC=1CN(C(=O)OC(C)(C)C)CCC1=CC=C(B(O)O)C=C1 HRUMHQQXUYKRJK-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 239000000048 adrenergic agonist Substances 0.000 description 2
- 229940126157 adrenergic receptor agonist Drugs 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 2
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 2
- ZFTFAPZRGNKQPU-UHFFFAOYSA-N dicarbonic acid Chemical compound OC(=O)OC(O)=O ZFTFAPZRGNKQPU-UHFFFAOYSA-N 0.000 description 2
- 229940043279 diisopropylamine Drugs 0.000 description 2
- 208000000718 duodenal ulcer Diseases 0.000 description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
- BYHUOJDCWGMPCF-UHFFFAOYSA-N ethyl 2-(4-bromo-2-cyclohexyloxyphenyl)acetate Chemical compound CCOC(=O)CC1=CC=C(Br)C=C1OC1CCCCC1 BYHUOJDCWGMPCF-UHFFFAOYSA-N 0.000 description 2
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 2
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 238000006317 isomerization reaction Methods 0.000 description 2
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- WNAFVJVEADYQAI-UHFFFAOYSA-N methyl 2-phenylbenzoate Chemical compound COC(=O)C1=CC=CC=C1C1=CC=CC=C1 WNAFVJVEADYQAI-UHFFFAOYSA-N 0.000 description 2
- ZHICBWUCPHAXEG-NDEPHWFRSA-N methyl 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]-[(2-methylpropan-2-yl)oxycarbonyl]amino]ethyl]phenyl]-2-propan-2-yloxybenzoate Chemical compound C1=C(OC(C)C)C(C(=O)OC)=CC=C1C(C=C1)=CC=C1CCN(C(=O)OC(C)(C)C)C[C@H](O)C1=CC=CC=C1 ZHICBWUCPHAXEG-NDEPHWFRSA-N 0.000 description 2
- DLZYFQPIEBOUGI-UHFFFAOYSA-N methyl 4-bromo-2-(2-methylpropoxy)benzoate Chemical compound COC(=O)C1=CC=C(Br)C=C1OCC(C)C DLZYFQPIEBOUGI-UHFFFAOYSA-N 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 2
- ICFQGMYPBURXAZ-UHFFFAOYSA-N pentane-1-sulfonamide Chemical compound CCCCCS(N)(=O)=O ICFQGMYPBURXAZ-UHFFFAOYSA-N 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- KJRCEJOSASVSRA-UHFFFAOYSA-N propane-2-thiol Chemical compound CC(C)S KJRCEJOSASVSRA-UHFFFAOYSA-N 0.000 description 2
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 2
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 2
- ZDYVRSLAEXCVBX-UHFFFAOYSA-N pyridinium p-toluenesulfonate Chemical compound C1=CC=[NH+]C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 ZDYVRSLAEXCVBX-UHFFFAOYSA-N 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
- LFKDJXLFVYVEFG-UHFFFAOYSA-N tert-butyl carbamate Chemical compound CC(C)(C)OC(N)=O LFKDJXLFVYVEFG-UHFFFAOYSA-N 0.000 description 2
- CCVFZAUFAZLPJI-IBGZPJMESA-N tert-butyl n-[3-(4-bromophenyl)propyl]-n-[(2r)-2-hydroxy-2-pyridin-3-ylethyl]carbamate Chemical compound C([C@H](O)C=1C=NC=CC=1)N(C(=O)OC(C)(C)C)CCCC1=CC=C(Br)C=C1 CCVFZAUFAZLPJI-IBGZPJMESA-N 0.000 description 2
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 125000001425 triazolyl group Chemical group 0.000 description 2
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- BWHDROKFUHTORW-UHFFFAOYSA-N tritert-butylphosphane Chemical compound CC(C)(C)P(C(C)(C)C)C(C)(C)C BWHDROKFUHTORW-UHFFFAOYSA-N 0.000 description 2
- HSKINQDVRZGRCZ-KLXURFKVSA-N (1r)-2-amino-1-pyridin-3-ylethanol;dihydrochloride Chemical compound Cl.Cl.NC[C@H](O)C1=CC=CN=C1 HSKINQDVRZGRCZ-KLXURFKVSA-N 0.000 description 1
- PMVFSIPPTOOMTI-FJXQXJEOSA-N (1r)-2-amino-1-pyridin-3-ylethanol;hydrochloride Chemical compound Cl.NC[C@H](O)C1=CC=CN=C1 PMVFSIPPTOOMTI-FJXQXJEOSA-N 0.000 description 1
- CQSLITZIZPAUOK-UHFFFAOYSA-N (3-cyclohexyloxy-4-methoxycarbonylphenyl)boronic acid Chemical compound COC(=O)C1=CC=C(B(O)O)C=C1OC1CCCCC1 CQSLITZIZPAUOK-UHFFFAOYSA-N 0.000 description 1
- KAECFWLUVLIQLM-UHFFFAOYSA-N (3-cyclohexyloxy-4-sulfamoylphenyl)boronic acid Chemical compound NS(=O)(=O)C1=CC=C(B(O)O)C=C1OC1CCCCC1 KAECFWLUVLIQLM-UHFFFAOYSA-N 0.000 description 1
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 description 1
- 125000006002 1,1-difluoroethyl group Chemical group 0.000 description 1
- 125000004504 1,2,4-oxadiazolyl group Chemical group 0.000 description 1
- 125000004506 1,2,5-oxadiazolyl group Chemical group 0.000 description 1
- 125000004517 1,2,5-thiadiazolyl group Chemical group 0.000 description 1
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 1
- 125000001781 1,3,4-oxadiazolyl group Chemical group 0.000 description 1
- 125000004520 1,3,4-thiadiazolyl group Chemical group 0.000 description 1
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 1
- MASDFXZJIDNRTR-UHFFFAOYSA-N 1,3-bis(trimethylsilyl)urea Chemical compound C[Si](C)(C)NC(=O)N[Si](C)(C)C MASDFXZJIDNRTR-UHFFFAOYSA-N 0.000 description 1
- WORJRXHJTUTINR-UHFFFAOYSA-N 1,4-dioxane;hydron;chloride Chemical compound Cl.C1COCCO1 WORJRXHJTUTINR-UHFFFAOYSA-N 0.000 description 1
- WHZJAGORNSGMDU-UHFFFAOYSA-N 1-(2-bromoethoxy)-4-iodobenzene Chemical compound BrCCOC1=CC=C(I)C=C1 WHZJAGORNSGMDU-UHFFFAOYSA-N 0.000 description 1
- YXZFFTJAHVMMLF-UHFFFAOYSA-N 1-bromo-3-methylbutane Chemical compound CC(C)CCBr YXZFFTJAHVMMLF-UHFFFAOYSA-N 0.000 description 1
- APTDRDYSJZQPPI-UHFFFAOYSA-N 1-bromo-4-(2-bromoethyl)benzene Chemical compound BrCCC1=CC=C(Br)C=C1 APTDRDYSJZQPPI-UHFFFAOYSA-N 0.000 description 1
- 125000001478 1-chloroethyl group Chemical group [H]C([H])([H])C([H])(Cl)* 0.000 description 1
- 125000004776 1-fluoroethyl group Chemical group [H]C([H])([H])C([H])(F)* 0.000 description 1
- HNEGJTWNOOWEMH-UHFFFAOYSA-N 1-fluoropropane Chemical group [CH2]CCF HNEGJTWNOOWEMH-UHFFFAOYSA-N 0.000 description 1
- PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- 125000004793 2,2,2-trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- 125000004778 2,2-difluoroethyl group Chemical group [H]C([H])(*)C([H])(F)F 0.000 description 1
- VRIOCSSBDAFBIT-OBRDHALPSA-N 2-(2-ethoxyethoxy)-4-[4-[2-[[(1r,2s)-1-hydroxy-1-phenylpropan-2-yl]amino]ethyl]phenyl]benzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OCCOCC)=CC(C=2C=CC(CCN[C@@H](C)[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 VRIOCSSBDAFBIT-OBRDHALPSA-N 0.000 description 1
- KFDRKURJOYACAD-LPCSYZHESA-N 2-(2-ethoxyethylamino)-4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-n-methylsulfonylbenzamide;dihydrochloride Chemical compound Cl.Cl.C1=C(C(=O)NS(C)(=O)=O)C(NCCOCC)=CC(C=2C=CC(CCNC[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 KFDRKURJOYACAD-LPCSYZHESA-N 0.000 description 1
- BSZBPLBCQSURFL-UQIIZPHYSA-N 2-(2-ethoxyethylsulfanyl)-4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]benzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(SCCOCC)=CC(C=2C=CC(CCNC[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 BSZBPLBCQSURFL-UQIIZPHYSA-N 0.000 description 1
- YPXOYYLOIMXHMB-JIDHJSLPSA-N 2-(2-fluoroethoxy)-4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-n-methylsulfonylbenzamide;hydrochloride Chemical compound Cl.C1=C(OCCF)C(C(=O)NS(=O)(=O)C)=CC=C1C(C=C1)=CC=C1CCNC[C@H](O)C1=CC=CC=C1 YPXOYYLOIMXHMB-JIDHJSLPSA-N 0.000 description 1
- PMOSJSPFNDUAFY-UHFFFAOYSA-N 2-(4-bromophenyl)ethanol Chemical compound OCCC1=CC=C(Br)C=C1 PMOSJSPFNDUAFY-UHFFFAOYSA-N 0.000 description 1
- NTFRPBIKBKHPHT-UHFFFAOYSA-N 2-(4-bromophenyl)ethyl carbamate Chemical compound NC(=O)OCCC1=CC=C(Br)C=C1 NTFRPBIKBKHPHT-UHFFFAOYSA-N 0.000 description 1
- UGTJLICWKXGKGF-JCOPYZAKSA-N 2-(cyclohexylamino)-4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethoxy]phenyl]benzoic acid;hydrochloride Chemical compound Cl.C([C@H](O)C=1C=CC=CC=1)NCCOC(C=C1)=CC=C1C(C=1)=CC=C(C(O)=O)C=1NC1CCCCC1 UGTJLICWKXGKGF-JCOPYZAKSA-N 0.000 description 1
- XSRZJMIJNKWTJY-LJAQVGFWSA-N 2-(cyclohexylamino)-4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-n-methylsulfonylbenzamide Chemical compound CS(=O)(=O)NC(=O)C1=CC=C(C=2C=CC(CCNC[C@H](O)C=3C=CC=CC=3)=CC=2)C=C1NC1CCCCC1 XSRZJMIJNKWTJY-LJAQVGFWSA-N 0.000 description 1
- IUMWWOXFHRLNAZ-UQIIZPHYSA-N 2-(ethoxymethyl)-4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]benzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(COCC)=CC(C=2C=CC(CCNC[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 IUMWWOXFHRLNAZ-UQIIZPHYSA-N 0.000 description 1
- VRPJIFMKZZEXLR-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid Chemical compound CC(C)(C)OC(=O)NCC(O)=O VRPJIFMKZZEXLR-UHFFFAOYSA-N 0.000 description 1
- MMOMNZLCOPSKFF-HKBQPEDESA-N 2-[2-cyclohexyloxy-4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]-[(2-methylpropan-2-yl)oxycarbonyl]amino]ethyl]phenyl]phenyl]acetic acid Chemical compound C([C@H](O)C=1C=CC=CC=1)N(C(=O)OC(C)(C)C)CCC(C=C1)=CC=C1C(C=1)=CC=C(CC(O)=O)C=1OC1CCCCC1 MMOMNZLCOPSKFF-HKBQPEDESA-N 0.000 description 1
- DWAHKXTVQWDCIY-PMERELPUSA-N 2-[2-cyclohexyloxy-4-[4-[2-[[(2r)-2-hydroxy-2-pyridin-3-ylethyl]-[(2-methylpropan-2-yl)oxycarbonyl]amino]ethyl]phenyl]phenyl]acetic acid Chemical compound C([C@H](O)C=1C=NC=CC=1)N(C(=O)OC(C)(C)C)CCC(C=C1)=CC=C1C(C=1)=CC=C(CC(O)=O)C=1OC1CCCCC1 DWAHKXTVQWDCIY-PMERELPUSA-N 0.000 description 1
- AKMHFYVVLMXTKO-MHZLTWQESA-N 2-[2-cyclohexyloxy-4-[4-[2-[[(2r)-2-hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]phenyl]acetic acid Chemical compound C([C@H](O)C=1C=NC=CC=1)NCCC(C=C1)=CC=C1C(C=1)=CC=C(CC(O)=O)C=1OC1CCCCC1 AKMHFYVVLMXTKO-MHZLTWQESA-N 0.000 description 1
- SUYHKARYJIVKRP-UHFFFAOYSA-N 2-amino-n-(4-iodophenyl)acetamide;hydrochloride Chemical compound Cl.NCC(=O)NC1=CC=C(I)C=C1 SUYHKARYJIVKRP-UHFFFAOYSA-N 0.000 description 1
- NPAKUVKFEVTCKC-UQIIZPHYSA-N 2-butoxy-4-[4-[2-[[(2r)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]ethoxy]phenyl]benzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OCCCC)=CC(C=2C=CC(OCCNC[C@H](O)C=3C=C(Cl)C=CC=3)=CC=2)=C1 NPAKUVKFEVTCKC-UQIIZPHYSA-N 0.000 description 1
- ZZNUVWNPOYKIJD-LURJTMIESA-N 2-chloro-5-[(2r)-oxiran-2-yl]pyridine Chemical compound C1=NC(Cl)=CC=C1[C@H]1OC1 ZZNUVWNPOYKIJD-LURJTMIESA-N 0.000 description 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 1
- JOVGEVBPTZGPQL-YCBFMBTMSA-N 2-cyclohexyloxy-4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethoxy]phenyl]benzoic acid;hydrochloride Chemical compound Cl.C([C@H](O)C=1C=CC=CC=1)NCCOC(C=C1)=CC=C1C(C=1)=CC=C(C(O)=O)C=1OC1CCCCC1 JOVGEVBPTZGPQL-YCBFMBTMSA-N 0.000 description 1
- BXEPAFFTNYOHPM-NDEPHWFRSA-N 2-cyclopentyl-4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethoxy]phenyl]-n-methylsulfonylbenzamide Chemical compound CS(=O)(=O)NC(=O)C1=CC=C(C=2C=CC(OCCNC[C@H](O)C=3C=CC=CC=3)=CC=2)C=C1C1CCCC1 BXEPAFFTNYOHPM-NDEPHWFRSA-N 0.000 description 1
- ZMSUUGGRCFHDKF-YCBFMBTMSA-N 2-cyclopentyl-4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]benzoic acid;hydrochloride Chemical compound Cl.C([C@H](O)C=1C=CC=CC=1)NCCC(C=C1)=CC=C1C(C=1)=CC=C(C(O)=O)C=1C1CCCC1 ZMSUUGGRCFHDKF-YCBFMBTMSA-N 0.000 description 1
- NLRHSFJRPAJMHY-JIDHJSLPSA-N 2-ethenyl-4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]benzoic acid;hydrochloride Chemical compound Cl.C([C@H](O)C=1C=CC=CC=1)NCCC(C=C1)=CC=C1C1=CC=C(C(O)=O)C(C=C)=C1 NLRHSFJRPAJMHY-JIDHJSLPSA-N 0.000 description 1
- YYPUQRNKJBGUNR-GKVSMKOHSA-N 2-ethoxy-4-[4-[2-[[(1R,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenyl]benzoic acid Chemical compound C1=C(C(O)=O)C(OCC)=CC(C=2C=CC(CCN[C@@H](C)[C@H](O)C=3C=CC(O)=CC=3)=CC=2)=C1 YYPUQRNKJBGUNR-GKVSMKOHSA-N 0.000 description 1
- JHOANROYSIHUBN-JIDHJSLPSA-N 2-ethoxy-4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-3-methylbenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OCC)=C(C)C(C=2C=CC(CCNC[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 JHOANROYSIHUBN-JIDHJSLPSA-N 0.000 description 1
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-M 2-methylbenzenesulfonate Chemical compound CC1=CC=CC=C1S([O-])(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 description 1
- 125000003229 2-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- 125000003504 2-oxazolinyl group Chemical group O1C(=NCC1)* 0.000 description 1
- GTKIGDZXPDCIKR-UHFFFAOYSA-N 2-phenylbenzamide Chemical compound NC(=O)C1=CC=CC=C1C1=CC=CC=C1 GTKIGDZXPDCIKR-UHFFFAOYSA-N 0.000 description 1
- TVVLYOPQYYREOW-UHFFFAOYSA-N 2-phenylbenzamide;hydrochloride Chemical compound Cl.NC(=O)C1=CC=CC=C1C1=CC=CC=C1 TVVLYOPQYYREOW-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- JMTMSDXUXJISAY-UHFFFAOYSA-N 2H-benzotriazol-4-ol Chemical compound OC1=CC=CC2=C1N=NN2 JMTMSDXUXJISAY-UHFFFAOYSA-N 0.000 description 1
- LJGHYPLBDBRCRZ-UHFFFAOYSA-N 3-(3-aminophenyl)sulfonylaniline Chemical group NC1=CC=CC(S(=O)(=O)C=2C=C(N)C=CC=2)=C1 LJGHYPLBDBRCRZ-UHFFFAOYSA-N 0.000 description 1
- PERYHCLELRXANQ-ASMAMLKCSA-N 3-(dimethylamino)-4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]benzoic acid;dihydrochloride Chemical compound Cl.Cl.CN(C)C1=CC(C(O)=O)=CC=C1C(C=C1)=CC=C1CCNC[C@H](O)C1=CC=CC=C1 PERYHCLELRXANQ-ASMAMLKCSA-N 0.000 description 1
- ISCMYZGMRHODRP-UHFFFAOYSA-N 3-(iminomethylideneamino)-n,n-dimethylpropan-1-amine Chemical compound CN(C)CCCN=C=N ISCMYZGMRHODRP-UHFFFAOYSA-N 0.000 description 1
- LFCWHVXIZBGDKX-QFIPXVFZSA-N 3-[4-[2-[[(2r)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]ethylamino]phenyl]benzoic acid Chemical compound C([C@H](O)C=1C=C(Cl)C=CC=1)NCCNC(C=C1)=CC=C1C1=CC=CC(C(O)=O)=C1 LFCWHVXIZBGDKX-QFIPXVFZSA-N 0.000 description 1
- FYSFTZURZZIYSV-QFIPXVFZSA-N 3-amino-4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]benzoic acid Chemical compound NC1=CC(C(O)=O)=CC=C1C(C=C1)=CC=C1CCNC[C@H](O)C1=CC=CC=C1 FYSFTZURZZIYSV-QFIPXVFZSA-N 0.000 description 1
- AMHUFKOXCSYREX-SNYZSRNZSA-N 3-butyl-4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]benzoic acid;hydrochloride Chemical compound Cl.CCCCC1=CC(C(O)=O)=CC=C1C(C=C1)=CC=C1CCNC[C@H](O)C1=CC=CC=C1 AMHUFKOXCSYREX-SNYZSRNZSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- 125000004208 3-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C([H])C(*)=C1[H] 0.000 description 1
- YUYXBLYSKPNXPT-UHFFFAOYSA-N 3-methylbutane-1-sulfonamide Chemical compound CC(C)CCS(N)(=O)=O YUYXBLYSKPNXPT-UHFFFAOYSA-N 0.000 description 1
- LYLJTYBJNZXRPE-UHFFFAOYSA-N 4-[4-(2-amino-2-methylpropyl)phenyl]-2-(2-methylpropyl)benzoic acid Chemical compound NC(CC1=CC=C(C=C1)C1=CC(=C(C=C1)C(=O)O)CC(C)C)(C)C LYLJTYBJNZXRPE-UHFFFAOYSA-N 0.000 description 1
- YUGKBDCURSYISL-UHFFFAOYSA-N 4-[4-(2-aminoethoxy)phenyl]-2-cyclohexyloxy-n-methylsulfonylbenzamide;hydrochloride Chemical compound Cl.CS(=O)(=O)NC(=O)C1=CC=C(C=2C=CC(OCCN)=CC=2)C=C1OC1CCCCC1 YUGKBDCURSYISL-UHFFFAOYSA-N 0.000 description 1
- OLBSFYAWEMEHLA-UHFFFAOYSA-N 4-[4-(2-aminoethyl)phenyl]-n-methylsulfonyl-2-(propan-2-ylamino)benzamide;dihydrochloride Chemical compound Cl.Cl.C1=C(C(=O)NS(C)(=O)=O)C(NC(C)C)=CC(C=2C=CC(CCN)=CC=2)=C1 OLBSFYAWEMEHLA-UHFFFAOYSA-N 0.000 description 1
- HZBACCFYWKQVGF-PIKZIKFNSA-N 4-[4-[(2r)-2-[[(2r)-2-hydroxy-2-phenylethyl]amino]propyl]phenyl]-2-(2-methylpropyl)-n-methylsulfonylbenzamide Chemical compound C1=C(C(=O)NS(C)(=O)=O)C(CC(C)C)=CC(C=2C=CC(C[C@@H](C)NC[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 HZBACCFYWKQVGF-PIKZIKFNSA-N 0.000 description 1
- HVEARHMGFIQQDL-VAMRJWDISA-N 4-[4-[1-[[(2r)-2-hydroxy-2-phenylethyl]amino]propan-2-yl]phenyl]-2-propan-2-yloxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OC(C)C)=CC(C=2C=CC(=CC=2)C(C)CNC[C@H](O)C=2C=CC=CC=2)=C1 HVEARHMGFIQQDL-VAMRJWDISA-N 0.000 description 1
- JIIPNLQSDWEJMM-VRECQLHDSA-N 4-[4-[2-[[(1r,2s)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenyl]-2-propan-2-yloxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OC(C)C)=CC(C=2C=CC(CCN[C@@H](C)[C@H](O)C=3C=CC(O)=CC=3)=CC=2)=C1 JIIPNLQSDWEJMM-VRECQLHDSA-N 0.000 description 1
- MTOVDKONOKZNFC-GYUFFBBGSA-N 4-[4-[2-[[(1r,2s)-1-hydroxy-1-phenylpropan-2-yl]amino]ethyl]phenyl]-2-propoxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OCCC)=CC(C=2C=CC(CCN[C@@H](C)[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 MTOVDKONOKZNFC-GYUFFBBGSA-N 0.000 description 1
- DUVDAJAXYHBDLL-VWLOTQADSA-N 4-[4-[2-[[(2R)-2-(4-aminophenyl)-2-hydroxyethyl]amino]ethyl]phenyl]-N-methylsulfonyl-2-propan-2-ylsulfanylbenzamide Chemical compound C1=C(C(=O)NS(C)(=O)=O)C(SC(C)C)=CC(C=2C=CC(CCNC[C@H](O)C=3C=CC(N)=CC=3)=CC=2)=C1 DUVDAJAXYHBDLL-VWLOTQADSA-N 0.000 description 1
- MBXVEWNJDSNZCT-LJAQVGFWSA-N 4-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-N-pentylsulfonyl-2-propan-2-yloxybenzamide Chemical compound C1=C(OC(C)C)C(C(=O)NS(=O)(=O)CCCCC)=CC=C1C(C=C1)=CC=C1CCNC[C@H](O)C1=CC=CC=C1 MBXVEWNJDSNZCT-LJAQVGFWSA-N 0.000 description 1
- AGUCCDQTFCLHNN-DEOSSOPVSA-N 4-[4-[2-[[(2r)-2-(3-aminophenyl)-2-hydroxyethyl]amino]ethoxy]phenyl]-2-propan-2-yloxybenzoic acid Chemical compound C1=C(C(O)=O)C(OC(C)C)=CC(C=2C=CC(OCCNC[C@H](O)C=3C=C(N)C=CC=3)=CC=2)=C1 AGUCCDQTFCLHNN-DEOSSOPVSA-N 0.000 description 1
- ZGYZKUVOZXMDDH-NDEPHWFRSA-N 4-[4-[2-[[(2r)-2-(3-aminophenyl)-2-hydroxyethyl]amino]ethyl]phenyl]-2-cyclohexyloxy-n-methylsulfonylbenzamide Chemical compound CS(=O)(=O)NC(=O)C1=CC=C(C=2C=CC(CCNC[C@H](O)C=3C=C(N)C=CC=3)=CC=2)C=C1OC1CCCCC1 ZGYZKUVOZXMDDH-NDEPHWFRSA-N 0.000 description 1
- GKJRPWPPZIETKU-VWLOTQADSA-N 4-[4-[2-[[(2r)-2-(3-aminophenyl)-2-hydroxyethyl]amino]ethyl]phenyl]-n-methylsulfonyl-2-propan-2-yloxybenzamide Chemical compound C1=C(C(=O)NS(C)(=O)=O)C(OC(C)C)=CC(C=2C=CC(CCNC[C@H](O)C=3C=C(N)C=CC=3)=CC=2)=C1 GKJRPWPPZIETKU-VWLOTQADSA-N 0.000 description 1
- UPWOKBWOTDEGOQ-UQIIZPHYSA-N 4-[4-[2-[[(2r)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]ethoxy]phenyl]-2-(2-methylpropoxy)benzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OCC(C)C)=CC(C=2C=CC(OCCNC[C@H](O)C=3C=C(Cl)C=CC=3)=CC=2)=C1 UPWOKBWOTDEGOQ-UQIIZPHYSA-N 0.000 description 1
- FJTAGRLRABWGCD-SNYZSRNZSA-N 4-[4-[2-[[(2r)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]ethoxy]phenyl]-2-(2-methylpropyl)benzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(CC(C)C)=CC(C=2C=CC(OCCNC[C@H](O)C=3C=C(Cl)C=CC=3)=CC=2)=C1 FJTAGRLRABWGCD-SNYZSRNZSA-N 0.000 description 1
- VFEAJBBIVVIQDG-JIDHJSLPSA-N 4-[4-[2-[[(2r)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]ethoxy]phenyl]-2-propan-2-yloxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OC(C)C)=CC(C=2C=CC(OCCNC[C@H](O)C=3C=C(Cl)C=CC=3)=CC=2)=C1 VFEAJBBIVVIQDG-JIDHJSLPSA-N 0.000 description 1
- HJBVLKQMEXFTFU-JIDHJSLPSA-N 4-[4-[2-[[(2r)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]ethoxy]phenyl]-2-propoxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OCCC)=CC(C=2C=CC(OCCNC[C@H](O)C=3C=C(Cl)C=CC=3)=CC=2)=C1 HJBVLKQMEXFTFU-JIDHJSLPSA-N 0.000 description 1
- LGLAZESVQVTTIB-SNYZSRNZSA-N 4-[4-[2-[[(2r)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]ethyl]phenyl]-3-(2-methylpropyl)benzoic acid;hydrochloride Chemical compound Cl.CC(C)CC1=CC(C(O)=O)=CC=C1C(C=C1)=CC=C1CCNC[C@H](O)C1=CC=CC(Cl)=C1 LGLAZESVQVTTIB-SNYZSRNZSA-N 0.000 description 1
- URDQAJFRADQJGR-JIDHJSLPSA-N 4-[4-[2-[[(2r)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]ethyl]phenyl]-3-ethylbenzoic acid;hydrochloride Chemical compound Cl.CCC1=CC(C(O)=O)=CC=C1C(C=C1)=CC=C1CCNC[C@H](O)C1=CC=CC(Cl)=C1 URDQAJFRADQJGR-JIDHJSLPSA-N 0.000 description 1
- ZEWQAVIVDFTLSP-UQIIZPHYSA-N 4-[4-[2-[[(2r)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]ethyl]phenyl]-3-propylbenzoic acid;hydrochloride Chemical compound Cl.CCCC1=CC(C(O)=O)=CC=C1C(C=C1)=CC=C1CCNC[C@H](O)C1=CC=CC(Cl)=C1 ZEWQAVIVDFTLSP-UQIIZPHYSA-N 0.000 description 1
- HUIXYXIMTYLEAI-JIDHJSLPSA-N 4-[4-[2-[[(2r)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]ethylamino]phenyl]-2-propoxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OCCC)=CC(C=2C=CC(NCCNC[C@H](O)C=3C=C(Cl)C=CC=3)=CC=2)=C1 HUIXYXIMTYLEAI-JIDHJSLPSA-N 0.000 description 1
- NDWPPVQVXQFNAM-FTBISJDPSA-N 4-[4-[2-[[(2r)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]ethylamino]phenyl]benzoic acid;hydrochloride Chemical compound Cl.C([C@H](O)C=1C=C(Cl)C=CC=1)NCCNC(C=C1)=CC=C1C1=CC=C(C(O)=O)C=C1 NDWPPVQVXQFNAM-FTBISJDPSA-N 0.000 description 1
- VTKMLZIGOBSURB-NDEPHWFRSA-N 4-[4-[2-[[(2r)-2-(4-aminophenyl)-2-hydroxyethyl]amino]ethyl]phenyl]-2-cyclohexyloxy-n-methylsulfonylbenzamide Chemical compound CS(=O)(=O)NC(=O)C1=CC=C(C=2C=CC(CCNC[C@H](O)C=3C=CC(N)=CC=3)=CC=2)C=C1OC1CCCCC1 VTKMLZIGOBSURB-NDEPHWFRSA-N 0.000 description 1
- PQIYAYICSPPBOY-WLOLSGMKSA-N 4-[4-[2-[[(2r)-2-(4-aminophenyl)-2-hydroxyethyl]amino]ethyl]phenyl]-n-methylsulfonyl-2-propan-2-yloxybenzamide;dihydrochloride Chemical compound Cl.Cl.C1=C(C(=O)NS(C)(=O)=O)C(OC(C)C)=CC(C=2C=CC(CCNC[C@H](O)C=3C=CC(N)=CC=3)=CC=2)=C1 PQIYAYICSPPBOY-WLOLSGMKSA-N 0.000 description 1
- WOFBNUYARXYLNQ-WLOLSGMKSA-N 4-[4-[2-[[(2r)-2-(4-aminophenyl)-2-hydroxyethyl]amino]ethyl]phenyl]-n-methylsulfonyl-2-propoxybenzamide;dihydrochloride Chemical compound Cl.Cl.C1=C(C(=O)NS(C)(=O)=O)C(OCCC)=CC(C=2C=CC(CCNC[C@H](O)C=3C=CC(N)=CC=3)=CC=2)=C1 WOFBNUYARXYLNQ-WLOLSGMKSA-N 0.000 description 1
- RADGEKGFCAQKLZ-JIDHJSLPSA-N 4-[4-[2-[[(2r)-2-(4-chlorophenyl)-2-hydroxyethyl]amino]ethoxy]phenyl]-2-propoxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OCCC)=CC(C=2C=CC(OCCNC[C@H](O)C=3C=CC(Cl)=CC=3)=CC=2)=C1 RADGEKGFCAQKLZ-JIDHJSLPSA-N 0.000 description 1
- ZYGRIOZJVGIXKT-SANMLTNESA-N 4-[4-[2-[[(2r)-2-(6-aminopyridin-3-yl)-2-hydroxyethyl]amino]ethyl]phenyl]-2-cycloheptyloxybenzoic acid Chemical compound C1=NC(N)=CC=C1[C@@H](O)CNCCC1=CC=C(C=2C=C(OC3CCCCCC3)C(C(O)=O)=CC=2)C=C1 ZYGRIOZJVGIXKT-SANMLTNESA-N 0.000 description 1
- DGHGBPNTKGVIFX-SANMLTNESA-N 4-[4-[2-[[(2r)-2-(6-aminopyridin-3-yl)-2-hydroxyethyl]amino]ethyl]phenyl]-2-cyclohexyloxy-n-methylsulfonylbenzamide Chemical compound CS(=O)(=O)NC(=O)C1=CC=C(C=2C=CC(CCNC[C@H](O)C=3C=NC(N)=CC=3)=CC=2)C=C1OC1CCCCC1 DGHGBPNTKGVIFX-SANMLTNESA-N 0.000 description 1
- DJTFHPYTDCJUNI-VWLOTQADSA-N 4-[4-[2-[[(2r)-2-(6-aminopyridin-3-yl)-2-hydroxyethyl]amino]ethyl]phenyl]-2-cyclohexyloxybenzoic acid Chemical compound C1=NC(N)=CC=C1[C@@H](O)CNCCC1=CC=C(C=2C=C(OC3CCCCC3)C(C(O)=O)=CC=2)C=C1 DJTFHPYTDCJUNI-VWLOTQADSA-N 0.000 description 1
- YPVVXDBWCDPNRB-QHCPKHFHSA-N 4-[4-[2-[[(2r)-2-(6-aminopyridin-3-yl)-2-hydroxyethyl]amino]ethyl]phenyl]-n-methylsulfonyl-2-propan-2-yloxybenzamide Chemical compound C1=C(C(=O)NS(C)(=O)=O)C(OC(C)C)=CC(C=2C=CC(CCNC[C@H](O)C=3C=NC(N)=CC=3)=CC=2)=C1 YPVVXDBWCDPNRB-QHCPKHFHSA-N 0.000 description 1
- MZFJYGKSUVMJCE-JIDHJSLPSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-(3-hydroxyphenyl)ethyl]amino]ethoxy]phenyl]-2-propoxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OCCC)=CC(C=2C=CC(OCCNC[C@H](O)C=3C=C(O)C=CC=3)=CC=2)=C1 MZFJYGKSUVMJCE-JIDHJSLPSA-N 0.000 description 1
- JRFSAWHPDAIKQA-JIDHJSLPSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-(3-hydroxyphenyl)ethyl]amino]ethyl]phenyl]-2-propan-2-yloxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OC(C)C)=CC(C=2C=CC(CCNC[C@H](O)C=3C=C(O)C=CC=3)=CC=2)=C1 JRFSAWHPDAIKQA-JIDHJSLPSA-N 0.000 description 1
- XJQYLEOYVGHTNH-VWLOTQADSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-[3-(methanesulfonamido)phenyl]ethyl]amino]ethyl]phenyl]-2-propan-2-yloxybenzoic acid Chemical compound C1=C(C(O)=O)C(OC(C)C)=CC(C=2C=CC(CCNC[C@H](O)C=3C=C(NS(C)(=O)=O)C=CC=3)=CC=2)=C1 XJQYLEOYVGHTNH-VWLOTQADSA-N 0.000 description 1
- MNTSPNDNPMLOLI-UQIIZPHYSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-[4-hydroxy-3-(methanesulfonamido)phenyl]ethyl]amino]ethyl]phenyl]-2-propan-2-yloxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OC(C)C)=CC(C=2C=CC(CCNC[C@H](O)C=3C=C(NS(C)(=O)=O)C(O)=CC=3)=CC=2)=C1 MNTSPNDNPMLOLI-UQIIZPHYSA-N 0.000 description 1
- PLNMLCMYSACQBI-MHZLTWQESA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]-[(2-methylpropan-2-yl)oxycarbonyl]amino]ethyl]phenyl]-2-propan-2-ylsulfanylbenzoic acid Chemical compound C1=C(C(O)=O)C(SC(C)C)=CC(C=2C=CC(CCN(C[C@H](O)C=3C=CC=CC=3)C(=O)OC(C)(C)C)=CC=2)=C1 PLNMLCMYSACQBI-MHZLTWQESA-N 0.000 description 1
- DUWLUHNLNLVQKL-YCBFMBTMSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]-2-methylpropyl]phenyl]-2-(2-methylpropyl)benzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(CC(C)C)=CC(C=2C=CC(CC(C)(C)NC[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 DUWLUHNLNLVQKL-YCBFMBTMSA-N 0.000 description 1
- NCHYFZMKHYDCDB-UQIIZPHYSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]-2-methylpropyl]phenyl]-2-propan-2-yloxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OC(C)C)=CC(C=2C=CC(CC(C)(C)NC[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 NCHYFZMKHYDCDB-UQIIZPHYSA-N 0.000 description 1
- ZQQFSHMZYQENFQ-UQIIZPHYSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethoxy]phenyl]-2-(2-methylpropoxy)benzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OCC(C)C)=CC(C=2C=CC(OCCNC[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 ZQQFSHMZYQENFQ-UQIIZPHYSA-N 0.000 description 1
- GNCDNSMZMLWRLI-SNYZSRNZSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethoxy]phenyl]-2-(2-methylpropyl)benzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(CC(C)C)=CC(C=2C=CC(OCCNC[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 GNCDNSMZMLWRLI-SNYZSRNZSA-N 0.000 description 1
- RKZCNGGGTNFYSP-JIDHJSLPSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethoxy]phenyl]-2-propan-2-yloxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OC(C)C)=CC(C=2C=CC(OCCNC[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 RKZCNGGGTNFYSP-JIDHJSLPSA-N 0.000 description 1
- NMHRJFOGAMSZNH-JIDHJSLPSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethoxy]phenyl]-2-propoxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OCCC)=CC(C=2C=CC(OCCNC[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 NMHRJFOGAMSZNH-JIDHJSLPSA-N 0.000 description 1
- CWNAROURWWJDLO-SNYZSRNZSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-2-(2-methylprop-1-enyl)benzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(C=C(C)C)=CC(C=2C=CC(CCNC[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 CWNAROURWWJDLO-SNYZSRNZSA-N 0.000 description 1
- OWSBFBQUELFZJC-SNYZSRNZSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-2-(oxan-4-yloxy)benzoic acid;hydrochloride Chemical compound Cl.C([C@H](O)C=1C=CC=CC=1)NCCC(C=C1)=CC=C1C(C=1)=CC=C(C(O)=O)C=1OC1CCOCC1 OWSBFBQUELFZJC-SNYZSRNZSA-N 0.000 description 1
- BACQNIUODFQAMD-VWLOTQADSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-2-(propan-2-ylamino)benzoic acid Chemical compound C1=C(C(O)=O)C(NC(C)C)=CC(C=2C=CC(CCNC[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 BACQNIUODFQAMD-VWLOTQADSA-N 0.000 description 1
- FYXDEHFZNKEFLQ-JIDHJSLPSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-2-propan-2-ylsulfanylbenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(SC(C)C)=CC(C=2C=CC(CCNC[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 FYXDEHFZNKEFLQ-JIDHJSLPSA-N 0.000 description 1
- FATBFAGUJKEWMH-SANMLTNESA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-2-pyridin-3-yloxybenzoic acid Chemical compound C([C@H](O)C=1C=CC=CC=1)NCCC(C=C1)=CC=C1C(C=1)=CC=C(C(O)=O)C=1OC1=CC=CN=C1 FATBFAGUJKEWMH-SANMLTNESA-N 0.000 description 1
- DHRJVNQWJAOHBA-SNYZSRNZSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-3-(2-methylpropyl)benzoic acid;hydrochloride Chemical compound Cl.CC(C)CC1=CC(C(O)=O)=CC=C1C(C=C1)=CC=C1CCNC[C@H](O)C1=CC=CC=C1 DHRJVNQWJAOHBA-SNYZSRNZSA-N 0.000 description 1
- XKWCWHLMRNLIBK-QHCPKHFHSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-3-(methylamino)benzoic acid Chemical compound CNC1=CC(C(O)=O)=CC=C1C(C=C1)=CC=C1CCNC[C@H](O)C1=CC=CC=C1 XKWCWHLMRNLIBK-QHCPKHFHSA-N 0.000 description 1
- YWQLKELWSSWGEU-UQIIZPHYSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-3-propylbenzoic acid;hydrochloride Chemical compound Cl.CCCC1=CC(C(O)=O)=CC=C1C(C=C1)=CC=C1CCNC[C@H](O)C1=CC=CC=C1 YWQLKELWSSWGEU-UQIIZPHYSA-N 0.000 description 1
- IZNUOCLGTSYWDZ-JCOPYZAKSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-n-(2-methylpropylsulfonyl)-2-propan-2-yloxybenzamide;hydrochloride Chemical compound Cl.C1=C(OC(C)C)C(C(=O)NS(=O)(=O)CC(C)C)=CC=C1C(C=C1)=CC=C1CCNC[C@H](O)C1=CC=CC=C1 IZNUOCLGTSYWDZ-JCOPYZAKSA-N 0.000 description 1
- ICEOZRUPAFOPHY-ROPHLPQBSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-n-methylsulfonyl-2-(propan-2-ylamino)benzamide;dihydrochloride Chemical compound Cl.Cl.C1=C(C(=O)NS(C)(=O)=O)C(NC(C)C)=CC(C=2C=CC(CCNC[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 ICEOZRUPAFOPHY-ROPHLPQBSA-N 0.000 description 1
- HKXUTOXQIDBDAL-UQIIZPHYSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-n-methylsulfonyl-2-propan-2-yloxybenzamide;hydrochloride Chemical compound Cl.C1=C(C(=O)NS(C)(=O)=O)C(OC(C)C)=CC(C=2C=CC(CCNC[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 HKXUTOXQIDBDAL-UQIIZPHYSA-N 0.000 description 1
- OHAITBKNXXWKSD-JMAPEOGHSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-n-pentylsulfonyl-2-propan-2-yloxybenzamide;hydrochloride Chemical compound Cl.C1=C(OC(C)C)C(C(=O)NS(=O)(=O)CCCCC)=CC=C1C(C=C1)=CC=C1CCNC[C@H](O)C1=CC=CC=C1 OHAITBKNXXWKSD-JMAPEOGHSA-N 0.000 description 1
- MGTABQLZLJTVGY-SANMLTNESA-N 4-[4-[2-[[(2r)-2-hydroxy-2-pyridin-3-ylethyl]-[(2-methylpropan-2-yl)oxycarbonyl]amino]ethyl]phenyl]-2-propan-2-ylsulfanylbenzoic acid Chemical compound C1=C(C(O)=O)C(SC(C)C)=CC(C=2C=CC(CCN(C[C@H](O)C=3C=NC=CC=3)C(=O)OC(C)(C)C)=CC=2)=C1 MGTABQLZLJTVGY-SANMLTNESA-N 0.000 description 1
- MHVMOYFJLPTJRQ-ASMAMLKCSA-N 4-[4-[2-[[(2r)-2-hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]-2-(2-methylpropoxy)benzoic acid;dihydrochloride Chemical compound Cl.Cl.C1=C(C(O)=O)C(OCC(C)C)=CC(C=2C=CC(CCNC[C@H](O)C=3C=NC=CC=3)=CC=2)=C1 MHVMOYFJLPTJRQ-ASMAMLKCSA-N 0.000 description 1
- FGAXSTBPLNYZAM-UHFFFAOYSA-N 4-[4-[2-[benzyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]ethyl]phenyl]-2-nitrobenzoic acid Chemical compound C=1C=CC=CC=1CN(C(=O)OC(C)(C)C)CCC(C=C1)=CC=C1C1=CC=C(C(O)=O)C([N+]([O-])=O)=C1 FGAXSTBPLNYZAM-UHFFFAOYSA-N 0.000 description 1
- KZUYYNGPRIFDBM-UHFFFAOYSA-N 4-[4-[2-methyl-2-(phenylmethoxycarbonylamino)propyl]phenyl]-2-(2-methylpropyl)benzoic acid Chemical compound C(C1=CC=CC=C1)OC(=O)NC(CC1=CC=C(C=C1)C1=CC(=C(C=C1)C(=O)O)CC(C)C)(C)C KZUYYNGPRIFDBM-UHFFFAOYSA-N 0.000 description 1
- BQPGJVPSURDCHL-SNYZSRNZSA-N 4-[4-[3-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]phenyl]-N-methylsulfonyl-2-propan-2-ylsulfanylbenzamide hydrochloride Chemical compound Cl.C1=C(C(=O)NS(C)(=O)=O)C(SC(C)C)=CC(C=2C=CC(CCCNC[C@H](O)C=3C=C(Cl)C=CC=3)=CC=2)=C1 BQPGJVPSURDCHL-SNYZSRNZSA-N 0.000 description 1
- GFAAHIVUKGTVEI-SANMLTNESA-N 4-[4-[3-[[(2R)-2-(4-aminophenyl)-2-hydroxyethyl]amino]propyl]phenyl]-N-methylsulfonyl-2-propan-2-yloxybenzamide Chemical compound C1=C(C(=O)NS(C)(=O)=O)C(OC(C)C)=CC(C=2C=CC(CCCNC[C@H](O)C=3C=CC(N)=CC=3)=CC=2)=C1 GFAAHIVUKGTVEI-SANMLTNESA-N 0.000 description 1
- MCFQTYGJSRYFQF-UQIIZPHYSA-N 4-[4-[3-[[(2r)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]phenyl]-2-propoxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OCCC)=CC(C=2C=CC(CCCNC[C@H](O)C=3C=C(Cl)C=CC=3)=CC=2)=C1 MCFQTYGJSRYFQF-UQIIZPHYSA-N 0.000 description 1
- KGILJOGFDPKXQD-UJXPALLWSA-N 4-[4-[3-[[(2r)-2-(4-aminophenyl)-2-hydroxyethyl]amino]propyl]phenyl]-2-cyclohexyloxy-n-methylsulfonylbenzamide;dihydrochloride Chemical compound Cl.Cl.CS(=O)(=O)NC(=O)C1=CC=C(C=2C=CC(CCCNC[C@H](O)C=3C=CC(N)=CC=3)=CC=2)C=C1OC1CCCCC1 KGILJOGFDPKXQD-UJXPALLWSA-N 0.000 description 1
- OUQGETIDOCDEPA-UQIIZPHYSA-N 4-[4-[3-[[(2r)-2-hydroxy-2-phenylethyl]amino]propyl]phenyl]-2-propan-2-yloxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OC(C)C)=CC(C=2C=CC(CCCNC[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 OUQGETIDOCDEPA-UQIIZPHYSA-N 0.000 description 1
- IGEIPJSQFNPDOM-UHFFFAOYSA-N 4-bromo-1-(chloromethyl)-2-cyclohexyloxybenzene Chemical compound ClCC1=CC=C(Br)C=C1OC1CCCCC1 IGEIPJSQFNPDOM-UHFFFAOYSA-N 0.000 description 1
- CWHRRBNUKIJGSG-UHFFFAOYSA-N 4-bromo-2-(3-methylbutyl)benzoic acid Chemical compound CC(C)CCC1=CC(Br)=CC=C1C(O)=O CWHRRBNUKIJGSG-UHFFFAOYSA-N 0.000 description 1
- ZVRJMVFGUUTEGP-UHFFFAOYSA-N 4-bromo-2-(cyclohexylamino)-n-methylsulfonylbenzamide Chemical compound CS(=O)(=O)NC(=O)C1=CC=C(Br)C=C1NC1CCCCC1 ZVRJMVFGUUTEGP-UHFFFAOYSA-N 0.000 description 1
- CHLIESQSABIWMH-UHFFFAOYSA-N 4-bromo-2-(cyclohexylamino)benzoic acid Chemical compound OC(=O)C1=CC=C(Br)C=C1NC1CCCCC1 CHLIESQSABIWMH-UHFFFAOYSA-N 0.000 description 1
- NRPCOCUZYRUHHG-UHFFFAOYSA-N 4-bromo-2-(propan-2-ylamino)benzoic acid Chemical compound CC(C)NC1=CC(Br)=CC=C1C(O)=O NRPCOCUZYRUHHG-UHFFFAOYSA-N 0.000 description 1
- JAVZWSOFJKYSDY-UHFFFAOYSA-N 4-bromo-2-chlorobenzoic acid Chemical compound OC(=O)C1=CC=C(Br)C=C1Cl JAVZWSOFJKYSDY-UHFFFAOYSA-N 0.000 description 1
- AUBOYMWDJAXDHN-UHFFFAOYSA-N 4-bromo-2-cyclohexyloxybenzoic acid Chemical compound OC(=O)C1=CC=C(Br)C=C1OC1CCCCC1 AUBOYMWDJAXDHN-UHFFFAOYSA-N 0.000 description 1
- PPBLYVKQODHYKU-UHFFFAOYSA-N 4-bromo-2-ethoxy-n-methylsulfonylbenzamide Chemical compound CCOC1=CC(Br)=CC=C1C(=O)NS(C)(=O)=O PPBLYVKQODHYKU-UHFFFAOYSA-N 0.000 description 1
- WNVOYJBTTPWDLA-UHFFFAOYSA-N 4-bromo-2-ethoxybenzoic acid Chemical compound CCOC1=CC(Br)=CC=C1C(O)=O WNVOYJBTTPWDLA-UHFFFAOYSA-N 0.000 description 1
- XNYBZLRIUHNRQY-UHFFFAOYSA-N 4-bromo-2-fluorobenzenesulfonyl chloride Chemical compound FC1=CC(Br)=CC=C1S(Cl)(=O)=O XNYBZLRIUHNRQY-UHFFFAOYSA-N 0.000 description 1
- VLVCDUSVTXIWGW-UHFFFAOYSA-N 4-iodoaniline Chemical compound NC1=CC=C(I)C=C1 VLVCDUSVTXIWGW-UHFFFAOYSA-N 0.000 description 1
- 125000006306 4-iodophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1I 0.000 description 1
- LUQVCHRDAGWYMG-UHFFFAOYSA-N 4-phenylbenzamide Chemical compound C1=CC(C(=O)N)=CC=C1C1=CC=CC=C1 LUQVCHRDAGWYMG-UHFFFAOYSA-N 0.000 description 1
- NNJMFJSKMRYHSR-UHFFFAOYSA-N 4-phenylbenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=CC=CC=C1 NNJMFJSKMRYHSR-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- FASWGZVJGUKPPX-UHFFFAOYSA-N CC(C)(C)OC(=O)N(CCC1=CC=C(C=C1)C2=C(C=C(C=C2)C(=O)O)[N+](=O)[O-])CC3=CC=CC=C3 Chemical compound CC(C)(C)OC(=O)N(CCC1=CC=C(C=C1)C2=C(C=C(C=C2)C(=O)O)[N+](=O)[O-])CC3=CC=CC=C3 FASWGZVJGUKPPX-UHFFFAOYSA-N 0.000 description 1
- AILCBYUGAUFNLA-NDEPHWFRSA-N CC(C)COC1=C(C=CC(=C1)C2=CC=C(C=C2)CCCN(C[C@@H](C3=CN=CC=C3)O)C(=O)OC(C)(C)C)C(=O)O Chemical compound CC(C)COC1=C(C=CC(=C1)C2=CC=C(C=C2)CCCN(C[C@@H](C3=CN=CC=C3)O)C(=O)OC(C)(C)C)C(=O)O AILCBYUGAUFNLA-NDEPHWFRSA-N 0.000 description 1
- RQPZQWPOCASFJO-UHFFFAOYSA-N CC(C)SC1=C(C=CC(=C1)C(=O)OC)C2=CC=CC=C2 Chemical compound CC(C)SC1=C(C=CC(=C1)C(=O)OC)C2=CC=CC=C2 RQPZQWPOCASFJO-UHFFFAOYSA-N 0.000 description 1
- 206010007027 Calculus urinary Diseases 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 206010063057 Cystitis noninfective Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- QPJVMBTYPHYUOC-UHFFFAOYSA-N Methyl benzoate Natural products COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 1
- 206010053236 Mixed incontinence Diseases 0.000 description 1
- 208000000693 Neurogenic Urinary Bladder Diseases 0.000 description 1
- 206010029279 Neurogenic bladder Diseases 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 206010036018 Pollakiuria Diseases 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010066218 Stress Urinary Incontinence Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- 208000000921 Urge Urinary Incontinence Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 208000028938 Urination disease Diseases 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- DGIMKFFHGWIJMP-UHFFFAOYSA-N [3-(2-fluoroethoxy)-4-(methylsulfonylcarbamoyl)phenyl]boronic acid Chemical compound CS(=O)(=O)NC(=O)C1=CC=C(B(O)O)C=C1OCCF DGIMKFFHGWIJMP-UHFFFAOYSA-N 0.000 description 1
- HXLNOBGZVOJCPZ-UHFFFAOYSA-N [3-cyclohexyloxy-4-(2-ethoxy-2-oxoethyl)phenyl]boronic acid Chemical compound CCOC(=O)CC1=CC=C(B(O)O)C=C1OC1CCCCC1 HXLNOBGZVOJCPZ-UHFFFAOYSA-N 0.000 description 1
- PXBBPDVMQYCJCR-UHFFFAOYSA-N [3-cyclohexyloxy-4-(methylsulfonylcarbamoyl)phenyl]boronic acid Chemical compound CS(=O)(=O)NC(=O)C1=CC=C(B(O)O)C=C1OC1CCCCC1 PXBBPDVMQYCJCR-UHFFFAOYSA-N 0.000 description 1
- MHDMXRMOVJCERM-UHFFFAOYSA-N [4-(methylsulfonylcarbamoyl)-3-propan-2-yloxyphenyl]boronic acid Chemical compound CC(C)OC1=CC(B(O)O)=CC=C1C(=O)NS(C)(=O)=O MHDMXRMOVJCERM-UHFFFAOYSA-N 0.000 description 1
- QECCDAGWSGKNIR-UHFFFAOYSA-N [4-methoxycarbonyl-3-(2-methylpropoxy)phenyl]boronic acid Chemical compound COC(=O)C1=CC=C(B(O)O)C=C1OCC(C)C QECCDAGWSGKNIR-UHFFFAOYSA-N 0.000 description 1
- QLQTZBFTWPEFPC-UHFFFAOYSA-N [4-methoxycarbonyl-3-(2-methylpropyl)phenyl]boronic acid Chemical compound COC(=O)C1=CC=C(B(O)O)C=C1CC(C)C QLQTZBFTWPEFPC-UHFFFAOYSA-N 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000000180 adrenergic beta-3 receptor agonist Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000002047 benzodioxolyl group Chemical group O1OC(C2=C1C=CC=C2)* 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004601 benzofurazanyl group Chemical group N1=C2C(=NO1)C(=CC=C2)* 0.000 description 1
- 125000005874 benzothiadiazolyl group Chemical group 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- WHDCKJUZKVXFND-PMERELPUSA-N benzyl n-[2-(4-bromophenyl)ethyl]-n-[(2r)-2-hydroxy-2-[3-(methanesulfonamido)-4-phenylmethoxyphenyl]ethyl]carbamate Chemical compound CS(=O)(=O)NC1=CC([C@@H](O)CN(CCC=2C=CC(Br)=CC=2)C(=O)OCC=2C=CC=CC=2)=CC=C1OCC1=CC=CC=C1 WHDCKJUZKVXFND-PMERELPUSA-N 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- RMHDLBZYPISZOI-UHFFFAOYSA-N borane;methylsulfanylmethane Chemical compound B.CSC RMHDLBZYPISZOI-UHFFFAOYSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- MCQRPQCQMGVWIQ-UHFFFAOYSA-N boron;methylsulfanylmethane Chemical compound [B].CSC MCQRPQCQMGVWIQ-UHFFFAOYSA-N 0.000 description 1
- 125000005997 bromomethyl group Chemical group 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- ARUJJNVNLJPSDO-UHFFFAOYSA-N butanamide;hydrochloride Chemical compound Cl.CCCC(N)=O ARUJJNVNLJPSDO-UHFFFAOYSA-N 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- DVECBJCOGJRVPX-UHFFFAOYSA-N butyryl chloride Chemical compound CCCC(Cl)=O DVECBJCOGJRVPX-UHFFFAOYSA-N 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N carbonic acid monoamide Natural products NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- USVVENVKYJZFMW-UHFFFAOYSA-N carboxyiminocarbamic acid Chemical compound OC(=O)N=NC(O)=O USVVENVKYJZFMW-UHFFFAOYSA-N 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 229910001919 chlorite Inorganic materials 0.000 description 1
- 229910052619 chlorite group Inorganic materials 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 1
- 125000003016 chromanyl group Chemical group O1C(CCC2=CC=CC=C12)* 0.000 description 1
- 201000003139 chronic cystitis Diseases 0.000 description 1
- 208000013507 chronic prostatitis Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- VJPGNAIPMMGCSU-UHFFFAOYSA-N cyclohexylmethanesulfonamide Chemical compound NS(=O)(=O)CC1CCCCC1 VJPGNAIPMMGCSU-UHFFFAOYSA-N 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 description 1
- FXORZKOZOQWVMQ-UHFFFAOYSA-L dichloropalladium;triphenylphosphane Chemical compound Cl[Pd]Cl.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 FXORZKOZOQWVMQ-UHFFFAOYSA-L 0.000 description 1
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Chemical compound CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- QMMFVYPAHWMCMS-UHFFFAOYSA-N dimethylsulfide Substances CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000001729 effect on metabolism Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- MWYJNZIJRKSBOC-UHFFFAOYSA-N ethyl 4-[4-(2-amino-2-methylpropyl)phenyl]-2-propan-2-ylsulfanylbenzoate Chemical compound C1=C(SC(C)C)C(C(=O)OCC)=CC=C1C1=CC=C(CC(C)(C)N)C=C1 MWYJNZIJRKSBOC-UHFFFAOYSA-N 0.000 description 1
- GNEAJWYAWTYGNE-UHFFFAOYSA-N ethyl 4-[4-[2-(benzylamino)ethyl]phenyl]-3-butylbenzoate Chemical compound CCCCC1=CC(C(=O)OCC)=CC=C1C(C=C1)=CC=C1CCNCC1=CC=CC=C1 GNEAJWYAWTYGNE-UHFFFAOYSA-N 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- BCQZXOMGPXTTIC-UHFFFAOYSA-N halothane Chemical compound FC(F)(F)C(Cl)Br BCQZXOMGPXTTIC-UHFFFAOYSA-N 0.000 description 1
- 229960003132 halothane Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000003451 hyperinsulinaemic effect Effects 0.000 description 1
- 201000008980 hyperinsulinism Diseases 0.000 description 1
- 208000006575 hypertriglyceridemia Diseases 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000005945 imidazopyridyl group Chemical group 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 238000001871 ion mobility spectroscopy Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 208000024714 major depressive disease Diseases 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 201000003995 melancholia Diseases 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- ZSGLAKVEUUXMBG-SFCXHYMASA-N methyl 2-amino-4-[4-[2-[benzyl-[(2r)-2-(oxan-2-yloxy)-2-phenylethyl]amino]ethyl]phenyl]benzoate Chemical compound C1=C(N)C(C(=O)OC)=CC=C1C(C=C1)=CC=C1CCN(CC=1C=CC=CC=1)C[C@@H](C=1C=CC=CC=1)OC1OCCCC1 ZSGLAKVEUUXMBG-SFCXHYMASA-N 0.000 description 1
- CIRLWCKMKNJVHC-YTTGMZPUSA-N methyl 2-cyclohexyloxy-4-[4-[3-[[(2r)-2-hydroxy-2-phenylethyl]-[(2-methylpropan-2-yl)oxycarbonyl]amino]propyl]phenyl]benzoate Chemical compound COC(=O)C1=CC=C(C=2C=CC(CCCN(C[C@H](O)C=3C=CC=CC=3)C(=O)OC(C)(C)C)=CC=2)C=C1OC1CCCCC1 CIRLWCKMKNJVHC-YTTGMZPUSA-N 0.000 description 1
- ZRBHEUPJVPCIHW-MHZLTWQESA-N methyl 2-ethylsulfanyl-4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]-[(2-methylpropan-2-yl)oxycarbonyl]amino]ethyl]phenyl]benzoate Chemical compound C1=C(C(=O)OC)C(SCC)=CC(C=2C=CC(CCN(C[C@H](O)C=3C=CC=CC=3)C(=O)OC(C)(C)C)=CC=2)=C1 ZRBHEUPJVPCIHW-MHZLTWQESA-N 0.000 description 1
- OJHMZWHKSAGJSZ-NDEPHWFRSA-N methyl 3-(dimethylamino)-4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]-[(2-methylpropan-2-yl)oxycarbonyl]amino]ethyl]phenyl]benzoate Chemical compound CN(C)C1=CC(C(=O)OC)=CC=C1C(C=C1)=CC=C1CCN(C(=O)OC(C)(C)C)C[C@H](O)C1=CC=CC=C1 OJHMZWHKSAGJSZ-NDEPHWFRSA-N 0.000 description 1
- FIAFCQOCWXUULV-UHFFFAOYSA-N methyl 4-[4-(2-amino-2-methylpropyl)phenyl]-2-(2-methylpropyl)benzoate Chemical compound C1=C(CC(C)C)C(C(=O)OC)=CC=C1C1=CC=C(CC(C)(C)N)C=C1 FIAFCQOCWXUULV-UHFFFAOYSA-N 0.000 description 1
- RCRFCDIKOVOWOQ-UHFFFAOYSA-N methyl 4-[4-(2-bromoethoxy)phenyl]-2-propan-2-ylsulfanylbenzoate Chemical compound C1=C(SC(C)C)C(C(=O)OC)=CC=C1C1=CC=C(OCCBr)C=C1 RCRFCDIKOVOWOQ-UHFFFAOYSA-N 0.000 description 1
- GXTYVWFXPKBJRB-UHFFFAOYSA-N methyl 4-[4-(2-hydroxyethoxy)phenyl]-2-propan-2-ylsulfanylbenzoate Chemical compound C1=C(SC(C)C)C(C(=O)OC)=CC=C1C1=CC=C(OCCO)C=C1 GXTYVWFXPKBJRB-UHFFFAOYSA-N 0.000 description 1
- BROWBKFKQZVTKN-UHFFFAOYSA-N methyl 4-[4-[2-(benzylamino)ethyl]phenyl]-2-(cyclohexylamino)benzoate Chemical compound COC(=O)C1=CC=C(C=2C=CC(CCNCC=3C=CC=CC=3)=CC=2)C=C1NC1CCCCC1 BROWBKFKQZVTKN-UHFFFAOYSA-N 0.000 description 1
- OYWCSKZUBNZORU-UHFFFAOYSA-N methyl 4-[4-[2-(benzylamino)ethyl]phenyl]-2-(propan-2-ylamino)benzoate Chemical compound C1=C(NC(C)C)C(C(=O)OC)=CC=C1C(C=C1)=CC=C1CCNCC1=CC=CC=C1 OYWCSKZUBNZORU-UHFFFAOYSA-N 0.000 description 1
- MZTJOSQMGQAVQE-NDEPHWFRSA-N methyl 4-[4-[2-[[(2r)-2-(3-aminophenyl)-2-hydroxyethyl]-[(2-methylpropan-2-yl)oxycarbonyl]amino]ethyl]phenyl]-2-propan-2-yloxybenzoate Chemical compound C1=C(OC(C)C)C(C(=O)OC)=CC=C1C(C=C1)=CC=C1CCN(C(=O)OC(C)(C)C)C[C@H](O)C1=CC=CC(N)=C1 MZTJOSQMGQAVQE-NDEPHWFRSA-N 0.000 description 1
- VSIRNRHUULOSMV-LJAQVGFWSA-N methyl 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]-[(2-methylpropan-2-yl)oxycarbonyl]amino]ethyl]phenyl]-2-(propan-2-ylamino)benzoate Chemical compound C1=C(NC(C)C)C(C(=O)OC)=CC=C1C(C=C1)=CC=C1CCN(C(=O)OC(C)(C)C)C[C@H](O)C1=CC=CC=C1 VSIRNRHUULOSMV-LJAQVGFWSA-N 0.000 description 1
- AJNYHIIZLWCODT-SANMLTNESA-N methyl 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]-[(2-methylpropan-2-yl)oxycarbonyl]amino]ethyl]phenyl]-2-methylsulfanylbenzoate Chemical compound C1=C(SC)C(C(=O)OC)=CC=C1C(C=C1)=CC=C1CCN(C(=O)OC(C)(C)C)C[C@H](O)C1=CC=CC=C1 AJNYHIIZLWCODT-SANMLTNESA-N 0.000 description 1
- MCBKUOYOXROHNJ-LJAQVGFWSA-N methyl 4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]-[(2-methylpropan-2-yl)oxycarbonyl]amino]ethyl]phenyl]-2-thiophen-2-ylbenzoate Chemical compound COC(=O)C1=CC=C(C=2C=CC(CCN(C[C@H](O)C=3C=CC=CC=3)C(=O)OC(C)(C)C)=CC=2)C=C1C1=CC=CS1 MCBKUOYOXROHNJ-LJAQVGFWSA-N 0.000 description 1
- KLFKICAURRGBKY-NDEPHWFRSA-N methyl 4-[4-[2-[[(2r)-2-hydroxy-2-pyridin-3-ylethyl]-[(2-methylpropan-2-yl)oxycarbonyl]amino]ethyl]phenyl]-2-(2-methylpropoxy)benzoate Chemical compound C1=C(OCC(C)C)C(C(=O)OC)=CC=C1C(C=C1)=CC=C1CCN(C(=O)OC(C)(C)C)C[C@H](O)C1=CC=CN=C1 KLFKICAURRGBKY-NDEPHWFRSA-N 0.000 description 1
- BKCBLWJIOZFTIA-XIFFEERXSA-N methyl 4-[4-[2-[benzyl-[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-2-(propan-2-ylamino)benzoate Chemical compound C1=C(NC(C)C)C(C(=O)OC)=CC=C1C(C=C1)=CC=C1CCN(CC=1C=CC=CC=1)C[C@H](O)C1=CC=CC=C1 BKCBLWJIOZFTIA-XIFFEERXSA-N 0.000 description 1
- RRYUVFWAKFOWLU-PMERELPUSA-N methyl 4-[4-[2-[benzyl-[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-2-nitrobenzoate Chemical compound C1=C([N+]([O-])=O)C(C(=O)OC)=CC=C1C(C=C1)=CC=C1CCN(CC=1C=CC=CC=1)C[C@H](O)C1=CC=CC=C1 RRYUVFWAKFOWLU-PMERELPUSA-N 0.000 description 1
- KRXFFDTVDRHNRQ-UHFFFAOYSA-N methyl 4-[4-[2-methyl-2-(phenylmethoxycarbonylamino)propyl]phenyl]-2-(2-methylpropyl)benzoate Chemical compound C1=C(CC(C)C)C(C(=O)OC)=CC=C1C(C=C1)=CC=C1CC(C)(C)NC(=O)OCC1=CC=CC=C1 KRXFFDTVDRHNRQ-UHFFFAOYSA-N 0.000 description 1
- LRHGEVRMVQAKSX-UHFFFAOYSA-N methyl 4-[4-[2-methyl-2-[(2,2,2-trifluoroacetyl)amino]propyl]phenyl]-2-propan-2-ylsulfanylbenzoate Chemical compound C1=C(SC(C)C)C(C(=O)OC)=CC=C1C1=CC=C(CC(C)(C)NC(=O)C(F)(F)F)C=C1 LRHGEVRMVQAKSX-UHFFFAOYSA-N 0.000 description 1
- UFOFFUGVBGMZHZ-LJAQVGFWSA-N methyl 4-[4-[3-[[(2r)-2-hydroxy-2-pyridin-3-ylethyl]-[(2-methylpropan-2-yl)oxycarbonyl]amino]propyl]phenyl]-2-(2-methylpropoxy)benzoate Chemical compound C1=C(OCC(C)C)C(C(=O)OC)=CC=C1C(C=C1)=CC=C1CCCN(C(=O)OC(C)(C)C)C[C@H](O)C1=CC=CN=C1 UFOFFUGVBGMZHZ-LJAQVGFWSA-N 0.000 description 1
- HERLATIXNZVIKI-UHFFFAOYSA-N methyl 4-bromo-2-(cyclohexylamino)benzoate Chemical compound COC(=O)C1=CC=C(Br)C=C1NC1CCCCC1 HERLATIXNZVIKI-UHFFFAOYSA-N 0.000 description 1
- NFEWHZWWMFPULE-UHFFFAOYSA-N methyl 4-bromo-2-(propan-2-ylamino)benzoate Chemical compound COC(=O)C1=CC=C(Br)C=C1NC(C)C NFEWHZWWMFPULE-UHFFFAOYSA-N 0.000 description 1
- JWOSXVMUUBWGOL-UHFFFAOYSA-N methyl 4-chloro-2-nitrobenzoate Chemical compound COC(=O)C1=CC=C(Cl)C=C1[N+]([O-])=O JWOSXVMUUBWGOL-UHFFFAOYSA-N 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- RYOXMNNNPXVWAI-NRFANRHFSA-N n-[5-[(1r)-2-[2-(4-bromophenyl)ethylamino]-1-[tert-butyl(dimethyl)silyl]oxyethyl]pyridin-2-yl]acetamide Chemical compound C1=NC(NC(=O)C)=CC=C1[C@@H](O[Si](C)(C)C(C)(C)C)CNCCC1=CC=C(Br)C=C1 RYOXMNNNPXVWAI-NRFANRHFSA-N 0.000 description 1
- VYPIMFJGKPSCGA-GXUZKUJRSA-N n-benzylsulfonyl-2-cyclohexyloxy-4-[4-[2-[[(2r)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]benzamide;hydrochloride Chemical compound Cl.C([C@H](O)C=1C=CC=CC=1)NCCC(C=C1)=CC=C1C(C=C1OC2CCCCC2)=CC=C1C(=O)NS(=O)(=O)CC1=CC=CC=C1 VYPIMFJGKPSCGA-GXUZKUJRSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 206010029446 nocturia Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 208000024449 overflow incontinence Diseases 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000005968 oxazolinyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- ULSIYEODSMZIPX-UHFFFAOYSA-N phenylethanolamine Chemical class NCC(O)C1=CC=CC=C1 ULSIYEODSMZIPX-UHFFFAOYSA-N 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 229960000395 phenylpropanolamine Drugs 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- 125000000612 phthaloyl group Chemical group C(C=1C(C(=O)*)=CC=CC1)(=O)* 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 1
- 229940116357 potassium thiocyanate Drugs 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- DROIHSMGGKKIJT-UHFFFAOYSA-N propane-1-sulfonamide Chemical compound CCCS(N)(=O)=O DROIHSMGGKKIJT-UHFFFAOYSA-N 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000001422 pyrrolinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000022170 stress incontinence Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- GPTXCAZYUMDUMN-UHFFFAOYSA-N tert-butyl n-(2-hydroxyethyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCO GPTXCAZYUMDUMN-UHFFFAOYSA-N 0.000 description 1
- UOYXWPMUUFPIDZ-IBGZPJMESA-N tert-butyl n-[(2r)-2-hydroxy-2-phenylethyl]-n-[2-(4-iodophenoxy)ethyl]carbamate Chemical compound C([C@H](O)C=1C=CC=CC=1)N(C(=O)OC(C)(C)C)CCOC1=CC=C(I)C=C1 UOYXWPMUUFPIDZ-IBGZPJMESA-N 0.000 description 1
- FSRZPRRAZVZKFE-NSHDSACASA-N tert-butyl n-[(2r)-2-hydroxy-2-phenylethyl]carbamate Chemical compound CC(C)(C)OC(=O)NC[C@H](O)C1=CC=CC=C1 FSRZPRRAZVZKFE-NSHDSACASA-N 0.000 description 1
- WSQWDAPZMYWNCG-NDEPHWFRSA-N tert-butyl n-[(2r)-2-hydroxy-2-pyridin-3-ylethyl]-n-[2-[4-[4-(methylsulfonylcarbamoyl)-3-(propan-2-ylamino)phenyl]phenyl]ethyl]carbamate Chemical compound C1=C(C(=O)NS(C)(=O)=O)C(NC(C)C)=CC(C=2C=CC(CCN(C[C@H](O)C=3C=NC=CC=3)C(=O)OC(C)(C)C)=CC=2)=C1 WSQWDAPZMYWNCG-NDEPHWFRSA-N 0.000 description 1
- MUZQTHLBMBNOOV-UXMRNZNESA-N tert-butyl n-[2-(4-bromophenyl)ethyl]-n-[(2r)-2-(oxan-2-yloxy)-2-phenylethyl]carbamate Chemical compound C([C@H](OC1OCCCC1)C=1C=CC=CC=1)N(C(=O)OC(C)(C)C)CCC1=CC=C(Br)C=C1 MUZQTHLBMBNOOV-UXMRNZNESA-N 0.000 description 1
- TVBQESYTDWRCSW-IBGZPJMESA-N tert-butyl n-[2-(4-bromophenyl)ethyl]-n-[(2r)-2-hydroxy-2-phenylethyl]carbamate Chemical compound C([C@H](O)C=1C=CC=CC=1)N(C(=O)OC(C)(C)C)CCC1=CC=C(Br)C=C1 TVBQESYTDWRCSW-IBGZPJMESA-N 0.000 description 1
- IJYMDQLEOPWKDN-HKBQPEDESA-N tert-butyl n-[2-[4-[4-(acetylsulfamoyl)-3-cyclohexyloxyphenyl]phenyl]ethyl]-n-[(2r)-2-hydroxy-2-phenylethyl]carbamate Chemical compound CC(=O)NS(=O)(=O)C1=CC=C(C=2C=CC(CCN(C[C@H](O)C=3C=CC=CC=3)C(=O)OC(C)(C)C)=CC=2)C=C1OC1CCCCC1 IJYMDQLEOPWKDN-HKBQPEDESA-N 0.000 description 1
- GNWLAIYDKTZJFJ-YTTGMZPUSA-N tert-butyl n-[2-[4-[4-(butanoylsulfamoyl)-3-cyclohexyloxyphenyl]phenyl]ethyl]-n-[(2r)-2-hydroxy-2-phenylethyl]carbamate Chemical compound CCCC(=O)NS(=O)(=O)C1=CC=C(C=2C=CC(CCN(C[C@H](O)C=3C=CC=CC=3)C(=O)OC(C)(C)C)=CC=2)C=C1OC1CCCCC1 GNWLAIYDKTZJFJ-YTTGMZPUSA-N 0.000 description 1
- XHARGCMWPVVNEE-UMSFTDKQSA-N tert-butyl n-[3-[4-[3-cyclohexyloxy-4-(propylsulfonylcarbamoyl)phenyl]phenyl]propyl]-n-[(2r)-2-hydroxy-2-phenylethyl]carbamate Chemical compound CCCS(=O)(=O)NC(=O)C1=CC=C(C=2C=CC(CCCN(C[C@H](O)C=3C=CC=CC=3)C(=O)OC(C)(C)C)=CC=2)C=C1OC1CCCCC1 XHARGCMWPVVNEE-UMSFTDKQSA-N 0.000 description 1
- PJUFNGOLTSWJHJ-NDEPHWFRSA-N tert-butyl n-[3-[4-[3-ethoxy-4-(methylsulfonylcarbamoyl)phenyl]phenyl]propyl]-n-[(2r)-2-hydroxy-2-phenylethyl]carbamate Chemical compound C1=C(C(=O)NS(C)(=O)=O)C(OCC)=CC(C=2C=CC(CCCN(C[C@H](O)C=3C=CC=CC=3)C(=O)OC(C)(C)C)=CC=2)=C1 PJUFNGOLTSWJHJ-NDEPHWFRSA-N 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000001984 thiazolidinyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- KJAMZCVTJDTESW-UHFFFAOYSA-N tiracizine Chemical compound C1CC2=CC=CC=C2N(C(=O)CN(C)C)C2=CC(NC(=O)OCC)=CC=C21 KJAMZCVTJDTESW-UHFFFAOYSA-N 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-M toluene-4-sulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-M 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- 125000005951 trifluoromethanesulfonyloxy group Chemical group 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 206010046494 urge incontinence Diseases 0.000 description 1
- 208000022934 urinary frequency Diseases 0.000 description 1
- 230000036318 urination frequency Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/56—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/63—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2003907111A AU2003907111A0 (en) | 2003-12-23 | Aminoalcohol Derivatives | |
| PCT/JP2004/019495 WO2005061433A2 (en) | 2003-12-23 | 2004-12-20 | Aminoalcohol derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA06007173A true MXPA06007173A (es) | 2006-08-23 |
Family
ID=34658494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA06007173A MXPA06007173A (es) | 2003-12-23 | 2004-12-20 | Derivados de aminoalcohol. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7417060B2 (enExample) |
| EP (1) | EP1697301A2 (enExample) |
| JP (1) | JP4618250B2 (enExample) |
| KR (1) | KR101071748B1 (enExample) |
| CN (1) | CN100582088C (enExample) |
| AR (1) | AR047351A1 (enExample) |
| CA (1) | CA2551167C (enExample) |
| MX (1) | MXPA06007173A (enExample) |
| TW (1) | TW200526551A (enExample) |
| WO (1) | WO2005061433A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ537206A (en) * | 2002-06-27 | 2007-06-29 | Astellas Pharma Inc | Aminoalcohol derivatives |
| US7423185B2 (en) | 2003-02-14 | 2008-09-09 | Kissei Pharmaceutical Co., Ltd. | Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof |
| WO2005040093A1 (ja) | 2003-10-24 | 2005-05-06 | Kissei Pharmaceutical Co., Ltd. | アミノアルコール誘導体、それを含有する医薬組成物およびそれらの用途 |
| EP1697301A2 (en) | 2003-12-23 | 2006-09-06 | Astellas Pharma Inc. | Aminoalcohol derivatives |
| WO2006022237A1 (ja) * | 2004-08-24 | 2006-03-02 | Kissei Pharmaceutical Co., Ltd. | 脂肪肝の予防または治療剤 |
| ATE452876T1 (de) * | 2004-09-21 | 2010-01-15 | Astellas Pharma Inc | Aminoalkoholderivate |
| JP5091663B2 (ja) * | 2005-03-16 | 2012-12-05 | 富山化学工業株式会社 | 新規なアントラニル酸誘導体またはその塩 |
| KR100901664B1 (ko) | 2007-08-06 | 2009-06-09 | 주식회사 오스코텍 | β-아미노알콜 유도체, 이의 제조방법 및 이를유효성분으로 함유하는 TNF-α 매개성 질환의 예방 및치료용 약학적 조성물 |
| IL310527A (en) * | 2015-10-23 | 2024-03-01 | B3Ar Therapeutics Inc | Zwitterion solvegron and its uses |
| CN116640074B (zh) * | 2023-05-22 | 2025-09-23 | 河北允升精细化工有限公司 | 一种合成5-氯-2-(2-氯乙氧基)苯磺酰胺的方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3718638A1 (de) * | 1987-06-04 | 1988-12-22 | Thomae Gmbh Dr K | Neue phenylethanolamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| NO179246C (no) * | 1991-11-20 | 1996-09-04 | Sankyo Co | Aromatiske amino-alkoholderivater og mellomprodukter til fremstilling derav |
| MX9708621A (es) * | 1995-05-10 | 1998-02-28 | Pfizer | AGONISTAS beta-ADRENERGICOS, COMPOSICIONES QUE LOS CONTIENEN Y USO DE LOS MISMOS. |
| GB9812709D0 (en) * | 1998-06-13 | 1998-08-12 | Glaxo Group Ltd | Chemical compounds |
| HUP0301382A2 (hu) * | 2000-10-20 | 2003-11-28 | Pfizer Products Inc. | Alfa-aril-etanol-amin-származékok és e vegyületeket tartalmazó béta-3 adrenergiás receptor agonista hatású gyógyászati készítmények |
| ATE386740T1 (de) * | 2001-11-20 | 2008-03-15 | Lilly Co Eli | Beta-3 adrenergische agonisten |
| DOP2003000587A (es) * | 2002-02-27 | 2003-08-30 | Pfizer Prod Inc | AGONISTAS DEL RECEPTOR ß3-ADRENERGICO |
| EP1478625A1 (en) * | 2002-02-27 | 2004-11-24 | Pfizer Products Inc. | Processes and intermediates useful in preparing beta-3-adrenergic receptor agonists |
| US20050090669A1 (en) * | 2002-03-14 | 2005-04-28 | Kouji Hattori | Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| NZ537206A (en) * | 2002-06-27 | 2007-06-29 | Astellas Pharma Inc | Aminoalcohol derivatives |
| AU2002952839A0 (en) | 2002-11-21 | 2002-12-05 | Fujisawa Pharmaceutical Co., Ltd. | Aminoalcohol derivatives |
| US7423185B2 (en) * | 2003-02-14 | 2008-09-09 | Kissei Pharmaceutical Co., Ltd. | Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof |
| EP1697301A2 (en) | 2003-12-23 | 2006-09-06 | Astellas Pharma Inc. | Aminoalcohol derivatives |
-
2004
- 2004-12-20 EP EP04807850A patent/EP1697301A2/en not_active Withdrawn
- 2004-12-20 MX MXPA06007173A patent/MXPA06007173A/es active IP Right Grant
- 2004-12-20 WO PCT/JP2004/019495 patent/WO2005061433A2/en not_active Ceased
- 2004-12-20 KR KR1020067014417A patent/KR101071748B1/ko not_active Expired - Fee Related
- 2004-12-20 JP JP2006520478A patent/JP4618250B2/ja not_active Expired - Fee Related
- 2004-12-20 CN CN200480041150A patent/CN100582088C/zh not_active Expired - Fee Related
- 2004-12-20 CA CA2551167A patent/CA2551167C/en not_active Expired - Fee Related
- 2004-12-21 US US11/016,886 patent/US7417060B2/en not_active Expired - Fee Related
- 2004-12-22 TW TW093139942A patent/TW200526551A/zh unknown
- 2004-12-27 AR ARP040104909A patent/AR047351A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2551167C (en) | 2011-10-18 |
| WO2005061433A3 (en) | 2005-10-27 |
| CN1906154A (zh) | 2007-01-31 |
| AR047351A1 (es) | 2006-01-18 |
| JP2007516211A (ja) | 2007-06-21 |
| CN100582088C (zh) | 2010-01-20 |
| US20050137236A1 (en) | 2005-06-23 |
| KR20070019678A (ko) | 2007-02-15 |
| JP4618250B2 (ja) | 2011-01-26 |
| EP1697301A2 (en) | 2006-09-06 |
| WO2005061433A2 (en) | 2005-07-07 |
| TW200526551A (en) | 2005-08-16 |
| CA2551167A1 (en) | 2005-07-07 |
| US7417060B2 (en) | 2008-08-26 |
| KR101071748B1 (ko) | 2011-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6495546B1 (en) | Propanolamine derivatives | |
| JP2003514793A (ja) | 消化管障害の治療に有用なアミノアルコール誘導体 | |
| MXPA04012783A (es) | Derivados de aminoalcohol. | |
| US7417060B2 (en) | Aminoalcohol derivatives | |
| IL181888A (en) | Aminoalcohol derivatives, pharmaceutical compositions containing the same and uses thereof | |
| WO2000012462A1 (en) | Aminoalcohol derivatives and their use as beta 3 adrenergic agonists | |
| TW200412337A (en) | Aminoalcohol derivatives | |
| AU2005285812B2 (en) | Aminoalcohol derivatives | |
| MXPA04008918A (es) | Derivados de aminoalcohol como agonistas del receptor adrenergico beta-3. | |
| US20050043371A1 (en) | Aminoalcohol derivatives and their use as beta 3 adrenergic agonists | |
| WO2005110981A1 (en) | Aminoalcohol derivatives | |
| ZA200406936B (en) | Aminoalcohol derivatives as beta-3 adrenergic receptor agonists. | |
| AU2006202092A1 (en) | Aminoalcohol derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |